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A. General 0 Emarks 
Attempts to find a suitable vaccine against tubercu-
'losis heve been mcde s~nce Yoch's discovery of t~e tubercle 
::bacillus. 'T'he l~st of substPnces trie(': i.s lo:1c C\:c f'ormida.ble, 
•' il 
: incl:'ding ,-;her:.olc; ted tuberculous s;mtur:J, the 1--:ovo c: cci::e of 
1 Pehrl"r::ry n!~riec,~nr··r'" i, 1-- ..l l(::_:.' _ ...... "L!lC..< l~.:. 0 turtle 1:;acillus, 11 A0 11·, vFrious tubercu-
, lins, anti~Jhyme..tol c:nd others, eecr, of' v.·(,icl> has ;~een 6iscBrd-
.ed 2fter original e~t~0siPstic support. Three ~ain lines of 
:I 
I' 
:research have been followed:l) injection of dee~ b2cllli, 
I' 
'2) injection of virulent bacilli a~6 3) injection of avirulent 
becilli. The first ~et~o~ does not give adeauate protection; 
·.the second is too risky. ':'his pe per is concerr..ec" v,'~ th a vee cine 
.:of the third t~Tpe, the widely publicized DCG. Ke.yne ( 105) eoti-
lme ted th t u~J to 1933 160C ert ~ c les had eppe~: red o.: t:_(C :::.ubjec t. 
I 
·The to tal literature contains me.n2: r!!ore, but t. e ecrly 1·:ork is 
I 
II 
.!me.rred by ineccurrte ste.tlstica.l e:'l?ly:::is e.no inl'' eruete 
I 
'controls. 
Living orEenisms ere the only 2~tisens s~~te~le for 
:.use in immunization, for atte~pts to produce refrsctorines~ to 
b. E 2 t. -1-: i J 1 e C. b2cl~li, c:eTiicrls or se-
ii 
~cretion products in cultures have nat been sufflcieLtly success-' 
'I 
' 
,ifu::.. Elcnoral FntiboC:ies heve not been sho1·:n to pl.sy co role in 
I ~ 
i 
'imrluniti' "'c·~'·nct •·ub~rc" 1 0<'l.""" +I-E o'E'·e 1 o·--·""El'l+ ! .1.: , _ ·.j cJ.c.c' ~~ . ...:- __ '. , c: '..A..L ~...: ,_., :. ..... ; ~ ..; .:. i.--ul ......... ~ ir.:-
I 
;munity is aseocictee with a ~ec~B~~s~ es yet unknown whic~ re-
;:strains the growth of tt.e baci lluE'. 
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as a result of previous infect~o~ E~d t: us possess a specific 
immu~ity against subsequent inf(ctio~s. A non-specific ~~turel 
resis~ance also eYlsts, but is va~ieble. Artlfici[l specific 
immunity stould bolster natural resistance a~a reduce the risk 
of prim2ry tuberculous infEction i~ people ~hose nFtural reels~ 
ta.nce is lo't'. 
Will BCG accomplish these results? Is the culture 
innocuous ar::d safe for administration to humrns? \·'h:~ t d(::c:ree of 
immuni-::y does it provide? Is tLere a.ny dencer of ret orn to its 
original high virulence? Can vaccination ~ith ?CG be used as 
a ro'J.tine public heal tlJ. measure? These e.re very L::~Jortent con-
sidereti~ns. ~his paper attempts to trece briefly the history 
of ~CG, its use in humans, its efficacy in i~munization a:d 
suggest fut~re possib~lities for its ~se. In view of the world-
wice experimentation an.d e.c~ninistrPtion of t:-~e vecciue, :::nd its .. 
fine.l acceptance fo:::o use in C"nited SteteB 2.nc ex:::)er2.:::r:sntc:tion 
' in Britain, a study such as this seems of dEfinite value. 
B. Historical Review 
~ocerd, in 1906, isolete6 a very virulent tovine 
brcillus fro~ e tuberculous cow.(sEe 49). Cal~ctte and Guerin 
c found it to srow well at 32 C. on 
potato sature~ed with 5~ glyccrinF+ed b1Je.(45,4E,~l,:3). !n 
1908 they reported th[t the bacilli he~ ecau·ree the property of 
easy of 
tubercle :Co.c·neti:J~-::. ;<'en 
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administered i~travenously to calves.(4~). 
Passcsss on the s~:ccrine-bile-poteto ~eclu~ were maee 
every 15 days. After L pa.sBee:es, e non-fetel a·LsE:Ese vTs pro-
ducec cattle toler&ted a 
dose which was previously fatal in 4 to~ weeks. (~0). After 
a stort interruption by the wer, passaces Efi6 i~~un~ty ex~er~-
ments we:::e resumed. At t:~e forty-second passa.ge virulence Yes 
retainEd for horses, and at the seventieth pessage a calf 
could tolerate 100 mg. intravenously. In 1;21, cfter pas-
sages on ~lyceri~ated-ox-biJe-potato medi~u, the cult:re was 
named Bacillus Calmette Guerin and dcclc:red inccpable of 
causins fetal tuberc~losis in cattle, horses, togs, monkeys, 
guinea piss or ra~cits. Subcutaneous inoculation of 0.5 to 1 
mg. in guinea .. piES (47) gave slight swe::'_ling et t~nE: site for 
tv.'O to t!cree V!eeks. Similar inoculetion of 5-10 me. proeuced 
sm2ll cold e.bscesses -r;l ict_ ulcerete{ ii: ti.:e tsnL: to tv,-elftL 
6ay, suppurFted in two to fou::: veets, then healed. The~c ~cs 
only slight trensito~~ c~lrrEement of the recion&l no~es. 
Celmette oris~nally claimed thet l) ~CG was nontuberculosenic, 
2) wes incapable of chan£e in virulence (a"virus fixe''), e~d 
3) did not procuce B.llergy but protectt::c .s.~·2ir:st s·.~bsecusnt 
development o:" L~. :_-erculosi s. A dose of E t leEs t ~L:, CCO bscll.li 
was stated at that ti~c to be bersless for ~e~. 
These announcemtnts started a~ im~ediate unfertaki~g 
of intense ani :mel e}:per•imen t& t ion L1 Frence encl o Y:er C·,".i'XCl tries 
with regard to future use on humans. Calmette's statements 
have been severely criticized and the real value or these can ::==--=---=--=.:::...::::::::=-=-~::=:.;;:__;._-:...::...__._-:;.::---=:..:::=-::::~::-=---:-_-==-~-==--=--=-==-:.=----==-::.:::"=::....~~-==_;;-:_~~--- ----- ·- ----- - - .z!_·: .. .=.;:;_-:__:;···-:..;.::==--:-==.; 
,I 
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{ 1 be ascertained from the disc~ssion thet is to follow. ':'he sub-
sequent story of BCG is a strange mixture of crit~cis~,-experi-




The general mEthod of experinentC?.tion has been to 
,! " non-infected e::1imals, 
'I 
fo:lowed by infection ~lt~ virulent ba-
;!' cilli tv.·o to :si:r ~r;onths leteT. Survivel t5_:'~c is not.,-:.c COEipc:red 
'I 
:: to contra ls, and po stmort:eo res:..1l ts are E~nslyzed. 
I' 
:! 
B .. ::iesul ts: 
Data gi~en in early rep~rts by Bcny investicators 
, upo::-1 cUf.fel'Cnt ani:r:als is surr;':-E.rized in Table l. Ite rr:a~o:r'i ty 
.· f~ ,-.L~ (""'!~ ... 
.!0 J.8pOrLoo od0\"1 that GCG provides so~e protection aEainst a viru-
,lECnt :Lnfection, bu-': L1is is not ebsolute. ::oviever, ce_l;;~ette's 
:i three c lc i.ms o.bovc. are not subs ta:1' iE tEe, for ?CG cloc s proc :..1 ce 
), 
! 
·:very mile loceli:7 ed disease \·ii h res·:ltins allerc~'. 
OthEr workers ~~o heve ee~onstrPted inhibition in 
~ incl'...i(e Isabolinsl:;;:y 8 ·<3 Gi toi>;i tsch( 102), Schm"bacher anc 1'~-ilson 
! 
(lEE), and Ian,~e end Iyd.tin (117). T)-"e letter vve:::--e '..~nc:ble tore-
proC:uce thE lEsions fo::...,r;;ed in guinea. ;>iss U~:l,-: s>..:bi:-:.oc:J.l[ tion 
cl er-Ilor:s tra.-
teo development of :Lmr::.u.ni ty in vacc in2ted rabbits. A s::-.1e 11 gi'oup 
RESULTS OF f·r.Jl~.:AL S'::'PDIIS TAELE I 4a 
~:UI PER 









2C rcc. IP 
2C nc. IC 
Orcl 
R.::.Sl7LTS 
Positive tuterculin reaction 
15 6ays aft6r vecc .. I~fe~!lon 
SC 6 ~onths lafer w1tn ?)( 
bacil1l. Yaccineted gro~p sur-
vived 2~ deys J~ncer t~an cen-
trals. ~ES~ltB DCfl~~.[lE: 
lCOd tuberculin ~os1t1ve 1n 
Eirkl1aue; ( 29) 
~ ~ '1 c 1 -:;· r-- ,-;·"'~ • . I") •• ,--. .. . c-~ 1-:~;- ~..- v:ce-~s, >-· Ln c. 1.cc. ~·· 
,, a cc L>r tee c·rO'''•J E'.TVi V6d 115 
d.evs 1on1=er -t:,er-: cont.l"ol~l cftcr 
vi~ulent-infectlon. Significant. 
!-'etl1od sirr:ilrr to above. Vace:. 
surviv6d lEl d~ys longer than 
co~trols. ~~ necrop2y eytcnsive 
lcr::on::: ~::- t;o:;."'c:cic c:~c Pi~co,.s·­
:~tl ort:E!·;s. 
/~tlsces~~ flor~ic· tto11 rt ti~oculc tior1 
site after ~-~ er~s. Vccc. sur-
\/i~.red 22Sl cSe~.'D lJ:lf!er· t.!·~r11 C:OY!-
tro l f,. 
No hypersens~tiveness ~eve~oped 
in c~inee ptES c~6 c2lvcs vocci-
nPteC o~Plly. In ~on~cy~, the ba-
cilli.. ·"l ·:-_c vrcci:e jc:::~~sc 1.:.s 
Found that 
pE re.r_ tera lly-
vecc.nc.ted 
animals e spec· 
~ elJ.:· C l"'E re l< 
t·'L vel;: t'f:icc <= 
refrPctory to 
Dror res:: i. ve t1 
2.fter virulen1 
S'..Jpt:rinfec ti or 
rs ~:Jn-vecc. c 
tro::_,,. 
King! Perk ( llC 
in_te~~-~~-l1r:-·l !~:t:co:.~·-c·, :_:_._··_( -~:r·oC:uccd 
hy~ercencltlveness r~c loc~lizeo 
tu~ercl€: ~n ~EsE~tcr·c ~acec. 
'"'::: c:::"'· 1;-:\::-, :::e-=s----,:_ ..... 1.---------.;l;-;C:::-, --0:;:;-r-P,l--c=.::;...;;;on-=t-=r...::o:_:l::-::-s.:::-,(...::j:.:.:e c~ \·' ~ L: i ::1 2'~ c: 2 ·.' 2 • · ::; 
L-I":"· r::,:>;reclable inc!'6cFed ~esi;tD!1Ce :?oxtor: (.!;4) 
G-uir:E e pies 
Retbi ts LfO 
11 
Cattle 127 




3-'3C 'n orally vr cc. CtLers li vecl for 
34-IV variouc pcr·otc up :o L yccrs. 
::-10m[~. IP 
Tocunowa c: 
Larionowe ( 22L 
3ch-vmrtz 
(169) 
C ,...,,-'. c::; 
20 6oilv ~o~ ha6 1atnt nositive tutercu-
doses i'~to i1'n 6 -rrk2. leter. Gross l.no0e 
conj unc ti va lesions, tu1)ercle s ·~n luncs 0f 
SC controls c:fter virulent in.fect'c.on. 
Vacc. h~d e~lrrged subMax.ond 
cervical noCc:, no l~clons in 
lungs, liver, soleen 
Vaccinetion renewed veerl··. Calmette et al 






rro~th norDil. Orconis~s ~c­
r::einec! locc: l L zed et L·:ocul: +:~O!'l 
·~i t.e f'r)llj>;" t>,·-,.,c. ,-.·Pte·-r ro 'IC'· ·,·. 
u - ' -~ ..... .. -- - .. - -·- '---" "-" ..:.. J - ... t-' ~ - • 
c. : 1~[. r~~~:t)j_ f- ~·;r6 t c c ""f c Cfr,o~1 -
~o:e fe~cl for co~~rol ~n ~C-
75 da.ys.·--~c_l~l~-j~-- of :ce2:~~t~-~-:ce 
efter 6 '~Or::-.;~'·. 
\Tc.cc. s:·:o 1:.~ec loDr·er 2t;::--q'"~·i "~lDl 
then coJ:trol:::, '~ter vi~-"Jlc:::·"t 
infecU.or'.. 
5-lC !n;:·. I Ca. Tuberculin ~Jo:~.~ ;~ ~vc :_,, ,.L_'.:; , .. ~".., ~c !D.f.'•. sc - ~·.C~/:.Oo 
10C-l~C~£.0ral(et 24 hr.i~terv,-ls,div~6ed i~to ten 
doses).Protection fro~ oculsr instil-
l< tl.o::~ o? 'J~r·Jlen~- ~:ccLll'. :f ::r 
6 :~o,-, +hs. 
Ce:•lE~ette et 







se til s~,o·,:cd resist~_ cs \·:: en ex- l·!il-~:ert (see 
nosed to n[turrl co~tact tnfec- 156) 
"l·l_ '=i ~-~ 
7LL:ps.nzee s 
Pithecic:n 
0 . 2D89 
..rUillEc .. ~J·-e:S 5E ---?r:- ':-.:::. 
21-lC:C;r::E'. 
SC,IV Ar'tc.r 12 , l ~ ,..,_f.rc._il a·-.a 
-·- _,~. i·;• q ~.- "';'C <'••nnc.nal· 0"' v •~ -· 
- ~ ~--_, e :- -V--~ ' U . ..).,;.:) "-'.i..I..W ·J. f~gm 8~nfected ~uinea pi~ inje~- Parish(l42) 




32 Graded ICer. Compared ~~.th si~ilar rro~o inoc-









culosis by inoculation with SCG, but s·nce the prepon6Erance 
of evidence is agEinst t~~s conclusion one ouestions whether 
contami~~tton, previous ey~osure or s;ontrneous tuberculosis 
may not have been respo~s~t"e. GenerDl cr~t"cisms of the an~-
mal experimentstion are th~t often too few animals ~ere used 
and t~ose used were not o:served lonr efiough. 
Tiedemann(2C5) and Suarez(20C) found no increase in 
virulence for guinea p~~cs after t~;e t;.·e~:tiett corneel :passage 
of BCU. Schwartz(l89) concluded from inocul~tions of res into 
guinea pigs at varying intervals in VPryinc doses in d~fferent' 
parts of t:e body that animals receivi~g a s~tcutaneous inocu~ 
lation into d~:_f::'erent pcorts of the boc~y s!.,ov:ec c: l~igher resis-, 
tance than diC t ose g~ven t~c same a~ount in irjectlon at one 
poirt. This finding is sign~ficant bece~se sirnil~r ob2ervatiotis 
led to the development of the multiple puncture method of 
vaccin~: ting ?Ean. 
c. Pathological ChanEBS r~e to ~ca: 
Radaody-Relarosy(l63) in 1939 found th2t ECS circu- • 
hours, L_en i nva.de6 t- 6 1 unLs, r-ople<c:n, L_ ver e ,,c tr2.cLeobron-
hicel lymph no6es. ~ot only was ttsre a specific re~ction 
with tubercle forrn~tion tut e gener2lized histiocytic res-
ponse seen prominently iG the se~tal cells of the lung, Kupfe~ 
cells of tYee liver,and reticulo-endothelial ce.Lls of the 
spleen. Similsr observ2tions have been ~ade efter experimentsil 
-6-
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· tween 77 end 125 d~ys Ffter vec:ination. ChiEri(61) reports 
that animals VE.ccir:ccteo '::'th .,-,cc: s: 01~ed 2.css LwoJvcr:er-.t of 
liver a~d spleE~ tte~ t~ose infected with o~~incry t~bcrcle 
bacilli. The center oft e foci sho~ed gr2rul:~ detritus a~d 
m&rl{ed exud:tion insterd of coc.gulc 4:ion necrosis. (see also H..:::;):. 
r. Kechanism of Actton: 
Lurie's experi~ents in 
may both interfere w~th developme~t of vtrule~t tubercle 
bacilli in thE';- body c:'d enc~ble tLs tis' ues to destroy Lem noret 
rapidly. :C'e founc tl·l·~t lcrge infecting c.oses .:;roduced little 
difference bet~een veccin2ted ecd controls. Ell infectL.g 
doses showed slo~er swelli~p of regional lymph nodes, slo~er 
development of tuberculin sensitivity, lon~er survival tiGe 
and less extensive, less severe lesions at necro)sy thEn the 
control a~imals. The geometric mean numbtr of colonies of ba-
cilll cultivated from t~e lunss ~ostmortcs W[S sPaller in the 
vaccinetec grou). ·~e .:)ostulc:-ted L.c:.t C.estruction of' i:;Bc~_ll~~ 
set in synchronously wilh the development of d~finite tubcrcu-
lin hypersensit~vity. ~ultiulicrtion u2u2lly occurreC in lymph 
nodes er:d continued t e~e e:~c~ in tLe spleeE 'rv·hsn other orgc;ns 
had acquired s~ffictent imnunity to meterielly rec~ce the 
number of b~cilli. 
Ascoli(9,l0) has theorized tt2t the presence of aviru-
lent bacilli causes cttrection of virulent becillL to the site 
and subsequent dest.ructio~~. In subste.nti_[·tion 01" t,,is uenecl:w-
resis '' theory he has stown in celves thct removal of the 





resistance. Until this work is confir2e0, the theory re2ains 
en intcrestinE speculation. 
A. Prepe.r& tion: 
Specific instructions were Eiven ~~ Calmette (2C2,also 
see 153) for the vaccine's prepe.rD tion e.r::d use. Bis s·.;s-
cestions are incorporeted into instructions Eiven by the 
Ne~ York Stete repartment of ~eelth w~ose present lar~e-
sce.le vaccinrtion pro~rem is headed by rr. Yonrsd ~irkhaug 
of ~'orv-,·e y. ( 129). These instruc t~ons are sumnari zed ·belm;. 
A glyce:::->o 1-bile-potc. to cu 1 ture and G gJ ."cerol-•.-:c. ter-pota to 
cult~re are maintlined contir::uousl~ and subcultured every 
two weeks, alternEtins eoch wes1t. T~e former is used for 
vaccine production, the latter for ettenuatio~ of virulence 
and 'reparction of stock cultures. 
Glycerolated-bile-)oteto c~lture 
~ 2 weeks ole 
Spread over flrt s~rface of slycerol-~ater-. 
/ 
~ato sleb Ln me6ium -2~ks incubation et 37.5°c. 
t;:: ~ 
Transfe·(~ to Sauton'e _me{ium Trensfsr to slycerol-
1 week incubttion water potEto 
~ (Sauton I) t 
Transfer to another flask 4~2 subcultures 
(Sautonii) ~ 
10-11 days Trensfer to glycerol-
Harvested for vaccine 
bile-potato for 1 or: 
2 biweekly passages 
\by 
. v 
. butomatic harvesting and dispensing appErat~s 





Shake semidry mass in crucible ~ith steel bells 
~ Oily paste 
---- ------ ------ ·--
... ....-~---- -----------
l
lO cc. diluent(l prrt Ssuton's medi~m, 
3 perts physiolocic saline) 
5omosenous sem~liqu~Zied ~aste 
/ riluent 
cutaneous metiod 9~ ~1. 6iluent 
20 mg. ~CG/n:l. for tre~ns-
1
: ml. ( lOCme> ~CG) end 
V 1. Or:;~-. r-cG/ml. for L: tra-
cutsneous vEccinatlon. 
Tests for virulence are ill[C6 by i~oculrtion into C~~~e~ 
pigs.and becterioloticul tests are ~e~e for p~rlt~. Calmette 
recomr::endec use.ce :lf a 25-day old Sauton r:::: cul turc for vacci-
ne tion, but Scandinavi al~. vwrkers heve found ti;e t ti1e ll c:e.y 
period gives a e;re.s te!" per cent oi' li vine be ci lli. TJ:~e vacc i11e 
is dispensed in 5-10 ml vials, lPtele{ thus: 
Div. of Laboratories aod R_,m 
N. Y. State Dept. of Health 
BCG VACCINE 
INYRACUTANIOUS 
1.0 Jq./ml. mL 
SHAKE WELL BEFORE USING 
KIIP IN RIPRIGIIlATOil 
No. Ret. 
Div. of Laboratories and Research 




20 mg./mi. ml 
SHAKE WELL IIFORI USING 
KEEP IN REFRIGIRATOR 
No. Ret. 
Ten units of penicillin /~1. are adeed to t~e 6il~ent to 
inhibit the growth of str]hylococci and streptococci turing 
the ten-day period in wtic~ the vaccinE ce~ be used. 
~eisfeiler in 1937 speculcted thet BCG vaccine would 
retain its effe0tiveness for long p~~io~s of ti~e if fried. 
Leschinskaya(ll9) has s~ccessfully used t~e vacu~~ met~oc of 
dryint; BCG v:i th subsequent trensplanto tion ln to e. ::u:- gL1-
case S'J L: tiOYl. Sue!; a vaccine can te s tor'e6 u.p to nine 




c~rtain precautions must ~e t~ken to assure beet 
results w_th t~e vecc~ne. ~hese i~cluCe: 
l. ~he culture must be fresh, v~{ t c vaccine used w~th-
in ten ~a~s of preperation to eli~inate use of deed 
b&ci 1li. 
2. Virulence tests to s::o1-v lc<ck of cep:o;city to procltwe 
progressive disease should be performed. 
3. remonstration of atsence of viruJent tubercle ba-
cilli from outside sources plus Ebsence of other pet~-
ogenic bacilli is important, and 
4. Prepcrstion of the vaccine ln c se?erate bu~lding 
into v:hich no o the~ culture o:C t-:_~bercle becillus 
enters is advised. 
C. Vethods of Vaccination: 
The search to f~_no tte method of vFce:~nr tion 1vhich 
would be easy to apply, give no g~oss local lesion, suppura-
dose of BCG h~:: s co~]t inuec t_ rou,shou t -::> c :leers. Successful 
methods have include6 t~e oral, subcutaneous, intrecut2neous, 
and trc:nscutc-:eous(sc::-rif:ca.tion Er_d ::Gult:~ple puncture meti:.ods):. 
Vaccerrezza et a1(21;,21~) heve used bucconasal adrn~nistrFtion:. 
by spray of 0.03 gm. BCG suspeneed in 3cc. of liquid divided 
into three portions. Eighty-six per cent of 56 chil(ren devel-
oped pos~tive tuberc~lin te2ts, usual=y Eround 30 deys later. 
This ~ethod, however, is too length~, reouires en assistant, 
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6 yeers. There is the added danger of lnhalction of the vac-
cine by t_e ph_vsi..ciR~1. ':lur (he.cussion i~-: lL:.l.+c~ to ti~e other 
methods. 
1. Oral:-Calmette b~see his reco~mendction of orel cdminls-
tration of DCG to infants upon Pesredka's tteory thet a local 
immunization s!::oulc-: be esteJ:lishec5 in tl-cose tJ.e;--ucs 1<:ici"', 2.re 
the portal of entry for ~he orgenism,e.s. the iGteEtlnPl tract. 
Vntil. t:.-~e ninth day of life -:-::e epithslium of t[ce intcstL1es 
was desonstrated to be syncytial, e fact presented in favor of 
invasion of orr::enisr::s ',·:hen c-;0:•:lnisterec orally. Cab:ette pres-
cribed three doses of lCC mf. eech given o~ the fourth, stxtt, 
eighth or fifth, seventh, of , ·i I"'" ( 5':) '~''"'e 4-....... ._ • \,) • ·"" .:...L 
total vaccin2tins dose is l,200,0CO,CCG bacilli. ?e~ clinical 
symptoms followed ad~inistration,but r~re crses of polyadeniti~ 
I 
were reported. This met~od w~s soon discorde~, ho~ever, because 
I 
tuberculin recctlons developed 1~ only 6-7. of tl1e subjects. 
2. Subcutar: ..eous:-':'his "Y-H:s introcuced -iJy ;·e·_ll-Fel}.e c:~O. 'I''Jr-
pin in l924.roses of 0.25-l.O ms., lPter C.Cl-0.02 ~g. were 
injected i::1to tt-,s scapuler ::r....,cc_:ion of Le ·ceck iL ti-e first v<ee};: 
of li~e. ':'he c~ief compllcetion w~s develoDE£~t of nodules 2~a 
smell ebscesses rt t~e site of i~jectio!. ~h~s wes present in 
o.ll gi <;en the le.rgcr dosss, bu'- only ir:: 3C of Lnse c· V6n ti"lE 
smaller doss s. reep L:jec ti on in to the loose subcut2.r~eous t ':. ssu.,t:;, 
ii 
e.c. tlle axilla, causec :ess 2bscess f~Jrn~ction tr,cn ir~ L_t.; 
lov;er 12 yers of tLe s"c~L.. :Kc;yne ( lC5) re ;:;o::."'ts 59·· nofule 
_.._ -- ·-···-·---
. _.., ~-·· ··---------
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formation in the Paris ~ecords of subcut~neous irjec~ions 
for 1928-1930. Yeresztur1 et al (109) renorted nodules ln 
abscesses in ~L:c·, 1:-'.0re frecuent vti th the lerger doses. Inguinal 
nodes were enlErged in L: 2 .. 
Stavropoulos(l99) found th£t of 196 subjects vecci~ated sub-
cutaneously, l9.E~ develope6 abscesses. 
3. Intracutaneous: WallGren began intracuta~eous injection 
in 1928(221). Fe use6 doses from 100 ~E· dovn to C.CS ~C· with 
no troublesome lesto~s resulting. Foci rcrel~ exceeded pea 
size, ~~th sl~~ht liquefaction, healt~l in r fe~ ~ceks. ~ow-
Ce _. v·' ""' n OC3 l l-"C::: v. ' to 0.03 ~[. found no le s ·', ons no2:1-necrot-
ic lesions in 47''t, end necrotic lesi_ons L~ L1l~ .A l:::ter B.nc;l;::-': 
Eirkhaug·(29) found e v:=ri.stion in per cent )f s~·IJ:::urctLg eb-
scesses from 23.6% to 10.4 4 in 12,919 persons veccin~ted from 
1938 to 1941. 
Lt. Transcutaneqys: !:n 1939, Rosenttel, et t· .. e ':'ice Labora.-. 
tories tn Chica[O vpcctnctef guinec P~ES 3~ t~nEential 
o:1 the skin. :·o visii::;le les~_on::: occurrE(, i:.:J.!t ellerc· appeored 
very early, e~f ell a~iDele still re2c~ed to tuberculin at 2 
months lrter 99-lCC~ were tuberculin positive. Onl~ pinhead 
-=-=---= 
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l\"egrs a::;d '3re tey ( 132) confirmec' Rosen tl:1al 's rc sul ts in 
animals, but re~laced the repeated puncture with superficial 
linear scrrification w~th a vaccine stylet. Four drops of BCG 
Suspens;on (c: ,-~--.- Icc ' ~rcrs ~ - :._J ~.!!f_: • / . • I , -l. ·_. - placed on t s 2rterEl 2S)eCt Of 
the t'<rr::, ~nc: t, rou;h eech orop 2 crosses of 1-2 c: •· lenE;th 
were made. Ioc[l reaction was sllsht, ly~ph no0e e~lLrse~ent 
"'errli rei "le ~"'orv•e(<o' ..,.,,,.:: P"r"f'(11L7) 0 1'+"l' '<8"~ "'l' p···i -lr::r re·'="'l Ls 1~ c. ---c-.-f ..... v J. --·:?) C"',_J..._;_ c· c_ -· I Ul..C' .. !.-. '---'- ..:_) ___ .._ __ L__ •.. ) ..... · ......... •. 
PirkhcW.£ ( 29) 
~e bas ~esigned an autom?tic sprlng instrument lt~ch Eakes 
40 punctures at one stroke. Papules developed in vaccincted 
by desquamation end disa)pe2rE~ce at 4-7 weeks. OccEsional 
cases showed tenderness of tte axillrry no~es. In 3,727 vac-
cinBtions ln L41-19L\2, '!_JUS \'las noted ;_t:l pGpules in 3.E'', 
positive tuberculin re2ct1.on 1.:1 97.5c'. 1'ytler(2ll) hrs l;c-.d 
re "'lLJl-'-s "'"~'ilrr to -r:>ir1-h"tJ.0' 1 S ir1 ~,-, w --~~~~-;.,__._, ___ c-... .-~ .t\.. .. -~-·C .-.c-.--~~ e~9eriment on guinea p~cs. 
From +:he point of vi..ew of t!1e cri teri.a '!:e:ltioned. at the 
beginning o! this discuss~an, t~e intr~cuteneous 2nd transcu-
taneous ~ethods seem to be t~e most deGlr~~le. After ~ore 
experience with Birkhaug's spp2ratus is gained a better 
evaluation of his results cen be made. 
- 13-
The Auto ffi t ic· BCG :ultipl e 
Punctur e App ratus. Pe i gb t 
., 2 ~ 
1. • ~) err. ' _a· ge s t d i eme t er 
( LJ . • 3 em. 
~~~~~~~~~~~~~~~~~~~~~~~~6=·-S=h=o~w~in~g~t~h~e~pa~t~te~JI~l of40 papules 3 weeks after 
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A. ~ignificance of Tuberculin Se~sitivity: 
BCG vaccination is reserved for those ~to erE nesative 
reactors to tuberculin. Conversion rfter vaccination requirei 
variable periods of time,e.g. 15 days to 4 months. mhat BCG 
converts negative into positive rerctors has been repeatedly 
demonstrated. The perc en ta.Ee of conversions variE: s, vri th the ' 
method used, but are usually greatest in the multiple p~nc-
ture and intracutaneous metho6s. ReveccinFtion may be perfor-: 
med upon those not positive_ to tuberculin after one year. 
Table 2 gives rtsults of several st~dies showing th[t tuber-
culin sensitivity develops in 73-100~ of 5CG vaccinated 
persons. 
B. Administra.tion to 2:nfants: 
On July 1,192l,Weill-Ealle administered BCG orally to 
an infant ~'-'l:O '::e s to be reared in a_ tube:cculou s i:ousehold. Tr1$ 
child maintained goo6 health, s0 in 1922 217 infants at I.e 
Charita Eospital,Paris, ¥ere vrccineted. After July 1924 the 
vaccine was distributed freely in France and made aVailable 
to foreign laboratories.(~0,51,223,224,22~,).From 1924 to 
rec.l9?7 52,772 infants were vacci:ate~ at tirth in Paris a~d, 
its e~virons. Of this number ~,749 were born of t~berculous 
mothers or l~vet in conta~ious surroun~incs. In the 3,£0[ who, 
had been veccinEte6 less than one ye.sr previous to rec.l927 
there -v,·ere 112 C:_ee.ths,pres.'m&.bly o£' tucerculous C:isc.sse. The 
generel sortrlity f~om all c.s ·_: se s for the v~ccineted ex~osed 
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Table 2. Degree of Tuberculin Reactivity in 
Several Studies (~edified from Levine,l22) 
p.l095 


































tallgrsn(22l) Intracutaneous II 
Gines and 
Richieri(90) 
































dren, Ten::. ! 
Infatlts unde~ 























the t;Eneral 1rortali ty wc:s 8. ::<, the t _;be.rculosis n.o:'teli ty 
24~. Of 1941 infants exposed to tuberculosis an~ vaccinated 
1-3 yea.rs there were 21 deaths, 4 of which v:e:ce due to tuber-
i 
culosis. 'T'he general r:JOrtali ty in tlcis grou.'J fror:1 all ce·)ses 
'•1' !=-.:. s 1 . ?o:· ,· t_ • ........ e +u.·,·~.· e-_,. c• .. 1.l o .~.-l· s •no ""t.., 1 l .... '' ·· • '1 "' :· ·, 'Y·'·1 P . ..., '" ·, t ~ c: c ,_ '-Y'<..·' ..._ , v _ _ •-' •-' :.l .L C._ I_,J l:,l...J_) '--'•·-,'-·• ... V>..J.l... -'-•'-• V-~ 
~erc~lin re~ction occurred in 6%. ~efinite protection was 
' 
shovn also by the oral voccin?tion exDeriments of vafi Bene6en 
(2l5,216),van den Ere.nden(218) anc Kereszturi(106). Ey tl:Je end 
of 1925, over 1~2,CCO chilCren had received the vaccine with-
oqt a~:y untowarc res~_,lts. Extensi';e vo.ccir:>.c.tions ,,,ere under-
taken in Fra.nce, Xon;ey, Sweden, renm2 .. rk, Rue.s ia, ArEentina, 
Brazil, Uruguay, Roumania and cana62. Ey 1930 the number 
vaccinated had reached 200,000; by 1934,1,343,000 and by 
the end of 1946 five million infants had been veccin~ted 
throughout the i·:or1d. 
Some of the important studies on hu~ans has been 
summarized in Table 3 and is presented later, but there are 
several studies which are significant and in some cases con-
troversia1 enoueh to merit mention. 
Wallgren (219,220,221) started in 192E to vaccinate 
every chiJ..d in Gothenburg, Sweden v;ho i·:as in dc:c;rcer of t'J.ber-
culous infection. Tuberculin-negative infents WEre vaccina-
ted intracutaneous1y with reG preceded and followed by six 
weeks of isolEtion from tuberc'J.lous surroundinEs. He cospared' 
the tuberculosis death rate for the years l912-192E before 
-lo-
vaccinetion to the rate for 1922-1933 when 230 in~ants were 
1000 for 1926-1933. The ec~J.l t rEte s~ o~,:e(~ only the E_'I'ec uel 
fall,D~roughout the worl~. 
Boynton(40) challenged Wallgren's conclusions,pur~ort-
ins to sho~ that in Kinnesota where BCG vaccinetio~ had not b~en 
tried, public health cetho~s hac ~ontrollef tuberculous mor-
tallty so thst the rate wEs lower and decreased sore rapidly 
than did tl'e t in Sv:ec en ':!i th u2e of ti·ce -:::cc- vFccL:.e. The rnor-, 
·tt?.lity rr:te of his gro·_,p(~:all;~ren's) for 1912-1916 V'ns l.J-30/ 
lOO,OCO,compared to ~innesota's 15~.7/lOO,OOO; ~:allgren's 
rates declined 9-3~ from 1912 to l92E,whereas ~innesota's 
declined 50;'(,. 
Anderson and Belfrace(see 32) followed up tallgren's 
end of 1945 they h2.d vrccinetec 41,2~;.5 persons,1o.6· of t!:e 
population of Gothenberg. Yo deaths fro~ tb hFd occurred 
among these, v:hil0 the tb :nort2li ty r.s te 1.::1 191;.:; v'EB Sc/lOC, 
000. ~'vienty-th:~ee cases of ber:.ign a '0 he alec' d i sec se B:c1d one 
case of proGressive )~lmoncry tuberculosis Jccurred among t~e 
vc.ccineted grY~7P· As can be reeC'ily seen, this etu6y is hB,::.-
pered by leek of contr~ls. ~allgren stctes thrt there :s not 
a sifuilar gr~up ave~leble for use as contr~ls because 
vaccination is seldom ref~sed. 
Aronson and r~nnenberg(5) reported on the oral vacci-, 
-17-
Controls were 114 white, 53 colore( infants. Tuberculin se~-
sitivity developed in El.61 of these vaccinated. The number 
of subjects is relatively s?.a,ll, but the results es sl~ow!l 
bela~ are favor2ble fJ0 BCG. 
Number 
41 






to open tuberc~losis 
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Vaccinated:ex)osed 
to closed tuberc~losis 






Even before the previous study was undertaken in Eal-
timore, Fereszturi and Park in recember 1926 had begun e. st'}dy 
on infants tn ~e~ York city. Children from fa~:lies with an 
open case of tu.erc losis, in the l-3yr.Ege gro~p, vith nege~ 
ti ve I:antoux, physice_l e:~am and X:.-ray '\4ere usee es s~1bjects. 
Oral vaccination was soon abandoned beca~se of small per-
centage of tuberculin conversio~s. The early work ~sed too 
few subjects,provided uneoual exposu~e f0r t~c two gro~]s 
and was further marred by the fact t~Pt me~bers of tuberculous 
faKilies were lnst~ucted rezardin6 protection of their chil-
dren,so t!at few of the exposed unvaccinated c~il6ren died. 
Later work eliminated ttese errors .After an eight year study 
tbey concluded thet BCG 1>:es har:·nless,e:lr" t~2st vo,cci.:let:..on 
resulted in devslolJmOlt of no clinic2l tu-oerculosis j_n tLose 
.:1ot exposed(7:)and in o~ly 5 o! t~e ~15 exp~sed subjects. In 
these l2tter the orga2isns isolated were of the hum&n type, 
--------~---------
- ....--- ---·---- --·----
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l ' ' presumably not BCG. (108,109,107). Results o:· 
study are presente~ below. 
Ore.lly vaccinated 
ECG c~1ildren 269 
P2rentere.lly ve.cci-
nPted BCG· children 421 
Controls knmm since 
birth 3h.r:::: . -' 
Controls not kno~~-n from 
birth 'l;'fi th nec;a.tive ini-
tial Eantoux test 410 
Total 144-5 
1 2 7. 4 
Tb ceeths Hon-tb 
deeths 
3 ( 1.1~;') 26(9.7") 
'·(0 T'~' 
_.. • /'- I 12 ( 2. (~:T~) 
9(~'"' ~0~., 
c:.. o.·:) r..r" I r-·· r-r.-~) cvt, ~-,. ( 
11(2.7%) 17 ( lj .1%) 






van den :Sergl)(217) reported Jn the or>al veccinE.tion of 
1, lCO infants over a period of 8~ yeers to 1935. ~:orte.li ty 
from tuberculosis in chiL"ren under 1 yr. ranc.ec from 2. 7-8% 
for the unvaccinated and 1.1-2.2~ for the vaccin~ted. Po 
harmful effect was noted from oral ad~:nistration. 
Hopkins(98) has recently revie~ed the work of rr. Eau-
do~in in ~ontreal (June l926-rec.l932) in which over 20,CCO 
infants were vaccin2ted. Careful followup was done on only 
793 ;·:["o ';,'ere vecc inc teo ex-~6 ex·po sed to tube::."'cu.losi s 2nd 1200 
not vaccinate6 but exposet to tuberculosis. The agcregote 
exposure of the controls to gen~ral risk was crerter.The 
a~erage age at the beginning of contact with a positive sputum 
case was not the same f~~ the two groups. These factors tend 
to invalidate the results but it is worth\·r~;ile no tine; th2 t in 
I 
. thE:O veccino ted r:roup there 1·;ere E dE:Eths Leo::". tuberculos j_s 
=====:-.::...-:::::----==-=;::=-..:.....,.___._~:..~-:-: ·=--=~= ~.=.=:~:--:_ __: -------------- ---- ~-~--=----=.- :;_-- .. -=:-.::::- .::..:..:...~-=--;:::--~---. 
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ity rete for the veccinated vas 31/lOO?for L:e vE.c:..irwtec, 
120/lCOO for the controls. 
Oral vaccination in Vru5uey was started in 1930, but 
he.s been :::1ore and :~wre a"bendonec in fEvor of parenteral ond 
multi9le puncture rnct~ofs. ~lanch et al (35) report that 
103,208 babies have been vEccinated; ~8,00~ orslly, 1~,302 
subcut~neously, 1,372 intracutaneo~sly, 12,359 by multiple 
pul!lcture. The mortality from tuberculosis in t_,E veccina ted 
was 1:, compared to mortality of 5.2~ in the controls. These 
investigators do not entertain an exaggerated enthusiasm for 
BCG vaccin~tion. All of the newly born since 194C(l7,0CO) 
ha~e been vaccinated with BCG and tatooed with in{elible ink 
on tbe plan tar espect of the lerge toe of tl'le left foot. The 
report·of Gomez differs from the above,for his analysis re-
vealed thst the mortality from tuberculosis amonc the vacc~ 
nated children was one-sixth that among nonvaccin~ted chil-
crepancy between these reports remains to be a0equately ex-
plained. 
The advent of ~orld War II retarded BCG experiments. 
Information upon !azi ezoerimcnts durin~ t~e war is still in-t 
.I.. c~ lr 
complete, but it has ~een reported that Turk, a ~azi dQctor, 
in 1942 inoculPted helf of a group of mentally retarded ch~l-, 
dren at the Vienna Clinic for Chil6ren's Disease,kesping the 
othsr half as controls. Some weeks later be inoculateC all 
=-n,c=~ ~- •T.~~~=~7thec -~-hi~1~,;~-;7·';i th"~ -c-i;t,~]_ d~~-se- of~'-~j_;~:Le~~ ,~~~-[)~;~=i~- bn~-~~~-: .=,==·=-=,-~= 
The vaccinated childre~ s~1owed no t~berculosis, but all con-
trols develJped active p~lmonary t~berculosls. On the strengbh 
of this inhumane experiment, BCG was officially odopte6 by the 
J?azis(85).T~is is a curious fincing in vie;-; of t.::~e foct thEt 
the ~,uisling health authorities in !:orway raided hee.l th bu-
reaus and schools to confiscate BCG literature and issued an 
official decree against BCG vaccin~tions and miniat0re X-rays. 
As 1;ras the ce se ivi th ma.ny '\vorthwhile tL ine_::s in Europe d. uri ng 
the war, BCG vaccinetion in Scandinavia "went undergroun~" 
and flourished.(33). 
Levine and Sackett(l21,122) have followed the result~ 
of Kereszt~ri and Park cited above and sum~arized results up 
to 1944. The study comprises 2,084 children o~ tuberculous 
families,l,Oll of vrtich '::ere veccinoted,l,.073 held es controls. 
At the beginning, an attempt was me~e to control t~e stuey by 
cl.ivic:.ing acceptec cr:ilcren into 2 eoual groups, a pLysician 
being instructed to vaccinate ha,lf of the:rr. It ~--'es fo· .. mc' th.st 
there was a tendency to inoculste children of the more intelli-
bent and cooperative pGrEnts and keep chilCren of noncooperetive 
pe,ren ts as controls. After Jan .1, 1933, the method of e.l ternet,e 
selection was used. Selections were made at teadcucrters and 
ass'lgned to st2f1' ped.i.etricians. This made e definite cHffer-· 
ence in results as shown in table follo~ing. 
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Tuberculosis Ieeths 
Cases Yumber Per cent 
Total Ce.ses 
BCG ve.ccinated 1,011 11 1.08 
Controls 1,073 26 2. ll-2 
Cases 12/15/26-1/1/33 
(before al terne.te 
selection) 
BCG vaccinatec 41!.5 3 0.68 
Controls 545 18 3.32 
Cases 1/1/3 3-1/1 I 4Lj. 
(after alternate 
selection) 
BCG ve.ccinated 566 8 1.41 
Controls 528 8 l. 51 
The routine seperation of chileren for three months 
before and three months after PCG vaccination was not found to 
be feasible or safe. However, in a limited number of exposed 
ce.ses i1:1 vt; .. :ich t'nie \·ta.s possible, 1.1% deaths f'ro:a tu!:.erculo-
sis occurred in the 91 veccinated subjects compared to 3.1~ 
tuberc~:losis dePths in the 96 nonveccine ted. Levine concluded 
that ro~tine vaccination with BCG of c~iltren froE tuberculous 
homes ~88 less advantageous t~En re2oval of t~r t~berculous 
subject f~ou t~e home. 
romingo(73) has had 2C years or ex~erience with ECG 
in Cuba. He believes that those observers who have used it in 
lO,OCC subjects and over are co~v~nce6 of its efficacy;others 
whose e~~erience hGS not been so wide are incline{ to 6oubt 
its value. St:.1dies in Greece have not bEen 1·;ell controlled, 
but Thsooos ( 204) has re)orted tLc>t in lnvestica tions fl"Om 
1925 to 1939 the morbidity of vaccin~ted children is one-
-22-
vaccinated chil6ren is one-seventh t~at o~ tte contro:s. 
In Belgium, 01brechts-Tyteca and Cltrechts(l43) made a 
deta~led study of 5,027 infants vac~in~te6 with BCG ond 
1,746 controls extending over 7 years. After allowi2~ ~or a 
numte~ of e~rors, they conclude ttat there is a slight dif-
ference ~n the Mortality figures in f~vor of t~c V?ccinated 
- ~·-· -~ ·-·-·- ------·-----
..... _ - -- -"- --- -·---
children. Infants were vaccinated in the lWr~ine ~uo~ia ~irqt ~ C·. ' "" ~ t.J i<....i "") ..L. ~o,.., 
in 1926. Mass vaccin~tion of the ne~born wcs begun in 1937. 
From 1937-1940, ti·!o :ni1J ion infants v;eYT VE: ccina tee- t:tro ·gho'l't 
tl-"e CJt~ntry, almost ell orally. At the end. of one; year the 
tuberculosis Eortality in the vEccin~ted Eroup was h£lf that 
of the controls. Abolnick(l) does not mention the sepsrEtion 
of infants from a tuberculous mil~eu. 
Assis bege,n VECcina.tion in FraziJ.. ,,,-j_th r:cG· ln. 192~. 
Up to 1944, 164,1~2 persons had been vaccinatet in ~io de 
Janeiro with 41,296 controls. Careful followup of this 
was not undertaken. Carvalho observed 38 vaccin2ted children 
e.nd 32 nonva.ccineted anc found a 20.6;' r:orbicJity,2.1?~ :Jorte.l-: 
ity in the veccinEted compFret to 39.6~ morbidlty,l3.2% mor-
tali ty in tLe nonvacc in2 ted. In c:_ s'Jrvey oi' several c::. stricts 
vrhEre the proportion of cl1ilc' ren 't!C'.S 70;' va ccin:" te6 to 3C;[ 
nonvacci~cted, active tuberculosis wcs found in the proportion 
of one vrccinrted child to five nonvaccin~?tec' .. Eueno(42)re-
gard.s this contrast as conclusive. 
Sayago et a.l.( 181) report the: t the total number 




in the vacct~·ted croup has ~een 8.3~ co~~rred to 1~.6~ in the 
controls. Chest X-rey exoninations ~n ttc VPCcLnEted zr8U9 
disclosed 57.5~ of lesions a~ong c~ilEren with tu~erculous 
e;ro'JP there vlere 74. Y' of lesi_ons L1 t£1ose \'.'\. th t'Jberculous 
contacts' 47. s-;r in t;;ose vi~ thou t. 
The nost recent re~ort on immunization of ~e~horn in-
fa.::ts heve "been g~ ven b~/ Posenthel et al from t'!e Tice Labora-, 
tories in Chicago(l71,177} as of January 1948. A ten-year 
tuberculosis mortality rcnced as hlch 2s 330/lCC,CCC Of 2,231 
infants 11 cases of tu!Jerculosis C.eveloped in t:-,e vRcc:•_nc:ted 
against 39 in the controls, a rate/1000 person-years of 3.31 
times creFter than the controls. One death fro8 tuberculosis 
occurred in the vacci_nc~ted agalnst 7 ire t:::-:E: contro:Ls. !n 1,1::9:1 
siblings they found the morbidity rete/lOCO person-yearc 5.29 
times as great in the controls as in the vaccinated. In the 
latter ~roup not only WFs there o su~pression of v•rulent in-
fection, but ..,,~hen v~ru2-ent infecti:Jn dl.d occur, v~,= lE-sions 
were less extens~ve, of shorter duration ana celcified eerlter' 
than lesions in the no~veccin~ted croup. The dif!erences in 
the groups are regarded as highly si~nific2nt because the popuJ 
lation in t~E [rOU)S bei!'l£:: COiTiyEred is Sh1iler,(l::'Lf,l77)-see 
Table 4. In a smaller study for 6 yeers on 699 children in ~ 
federal housing project who were veccin~ted and 625 
-24-
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vaccinoted, comp2re6 to 3 active cases i~ the controls. (17~). 
~ 
':::'ai.Jle 4. Rosenthal et ~1 (177).p.75. 









Cases of tuberculosis 
Total number 11 
Rate* 1.95 
Cases hospitalized ~ 
Number 
Rate* 0.17 
Ieaths from tuberculosis 
Number 1 
Rate* 0.17 
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**In 42 of the 54 deaths, or 77.71, autopsies or 
exaDinction verified the ce~se .of death. 
coroners' 
Pusik(l62) autopsied 57 chileren up to ase two wto 
had rec~ived BCG VEccine and hae died of nontuberculous dis-
eesE:s. He found a.r: sccumulc:tion of hi2tiocytic elerr:ents i.::-1 the 
lungs, periv~sculAr infiltrates in the liver, e~e hy)crplssia 
of the follicles of the spleen. Fourteen s~owed caseous les~ons 
in t~e lymph nodes, combine~ in three cases with typical tuber-




much critic ism, Calmette 's work he.s been attacked by Rosen-
feld(l67),Gotzl(Sl; ,Greenwood ( 92)Yirchner(ll2),Petroff(l53); 
van den Bergh(217),Berghaus(24),Epstein(78) and Goodwin(90), 
chiefly because: a) thG figure for the pe:r cent of c~-~iloren ofi 
the tu~erculous w~o died of tuberculosis in the first year or· 
life was exagserated(true figure 5%, his f~gure 24%),b) ~o 
controls were availeble for strict co~parison and c) diasnosas 
were seldom substa~tiated by autopsy. 
Inaccure.cies have crept into t~-~e v.ork, S'JCtl 0.s v2ccine.-
tion of large groups with followup of Bhl&ll fr0Ltlon :~i vi.nc::: a 
... _ ~· 
loss of differences of statistical sic~ificance. Even if 
sig~ificant differences were observed In conpar~ble groups, 
differences in sub~ecue~t medical or home c&re may eccou~t 
for the decrease i~ ~o~~ality and not ~CG. 
Control of experiments similar to t~ose here presented 
is truly difficult. ~·o study has m:: c_e ,,.!ention of 2ll tr"e vc:;_ri-
ables -intelligence ana cooperation of pErents, difference ~~ 
localities, fifferences t~ time of exDosure, r2ci2l flfferen~. 
- i 
ces, ase, maintenance of contact with all cases, identical 
followups and reliable d:2gnos1s at de~t:·. Levine and Sscket~'s 
analysis hc:s considered mc:ny of these vori~~:les. EovTever, ti1eir 
~ork is criticized for not Eiving per cent ~orbi~ity and not 
makiTig clear t~e &mount of exposure present ln the vccclnote~ 
~ 
: In sni te of the ='·==~c==#=-:c~:~='--·~~.c=co·-~oc ~cc·c=c=-==·--"'o-~-=c==~=-






I' =~7.c:=--...==cc~~JI==~--""'-"-c-~·-=c-==c-c.7-==.-c=---·-·. --- --·-· r": general trend-oT experi-mental results he s 
of tha~J e.ge.ins t ti~e use of" PCG. 
C. BCG Administration to Adults 
Tradition2lly it has been 'elieved thEt ~dult dise~se 
represents en c::te~·"sion of child.::looc L:-:f'ec L_ o~:::. Lately it is 
becoming c;·]pPrent tlwt com•o:only in t~::.e younc adult tu:;ercul-
ous diseose is the result o~ e ~ey infection rec:Ltly ac-
qulred, eL the:-c ::Ln e per·so:: prev~.ously uninfected or in o:OJe 
who has 2een i~fected :~ c~ildhood, rnd having recovered com, 
plo tely, he.s lost 2 1 e llersy <:: .. c' ::..r:t:-~uni t~' in the ·.ntervenL1g 
period. T,C> 
-.L this ls true, nursint: a~·"d medics.l students e.re 
exposed to peculiar tuberculous risk end cesc:cve all tl1e 
true that prim2ry inf~ction occurs frecucntly ufter age of 
18 or 20 and is more freouently acco~panied by grip-like 
symptoms, fevEr, e~d malaise then is usu: lly seen here.(l57)~ 
Daniels (71) in en Interim Report o~ the Prophit 
Trust Investigatio:1 Pl"esents evidence ti·!ct the risk of de-
velop:i.nc; tubercc;losis follov:in€._~ primcry infec ion of young 
adults is serious. He summarizes res~lts from 20 surveys i~ 
New Zealand on 13,03k nurses in the period of 1933-1941. The 
culin reactors, s.e~ among non-reactors. Daniels'fi~ures 
for 2120 further nurses in England and Yales ~ive 2.0~ aLd 





10';-:er in those who ~ere ~antoux positive on entry then in 
those who were negative. Ee concludes th2t e controlled 
method of Entituberculosis vaccination is needed fo~ nege-
tive resctors entering occu92tions of peculier exposure. 
Rosenthal(l73) found the 2verase mor~idity from 
tuberculosis for pupil nurses in the U.S. to :-,e "· r::(:)d r-<aa~ .,.e .... ·- _.,.· • _,) ; .. • _._. . l,) J.~: 
.. 
and Avasian(l2) have completed e follo,,'UP of the :1Urses ~.n 
training at Poston City ::ospi tel -~~1 ':he pt-:Plod 1935-1946. Of 
the 739 who entered duri~g that perio~, 
veloped k~berculosis ·by 1947. Levine's rE:.Csul ts e t ,.ichael 
Reese Fospi tal in Chicago give lo"::er fi~:_:ures ~han in any 
previous stuty, e.f. G.34-0.45% morbi&· ty. 
l. !-::urses: A classic study upon pupil nurses ~~ that of 
~eimbeck at t~e UllevaPl Fos)ital, Oslo. (9~,?5). In 1924 
tuberculin tests and p~ysical exam:n2t~ons ~e~-e ~~de oblifa-
tory for all pupil nurses entering the hos)ital. Fro~ 50f 
to 60~ were non-reactors, but most became positive Efter one. 
year's serv~ce on open hospital ~&rds and all after 3 years 
training. Intracutaneous RCG vacci~~t~on of nesative re1 ctors 
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nurses at Saskstchewan Gener2l ~ospitel,Formerl2 35~ of the 
nurses(tuberculin pos~tives) and 12~ of the t~berculin nesa-
tives became infected duriLg the traini~g per~od, Sixty per 
cent o:r ti1e e.:r:.ployees bece.rne L1fected (urL:_t_' the first year of 
exposure. Of 1005 ECG vaccinated nurses 9t0~9~)ecqulred tuber-
culosis, whereus of 759 unvscci~eted tuberculi~ nesative 
n"'J."'C?"S 0 0( 7 • f.:;<\ nC'Q_ 11 -ired 1-,'-erCUl0'-'-1 " ( J.r_ T- 'nne '"' ---'~ .--,,.' ,'"'\f' ,.\.A\......!- C:. . .,/ .,/e'-'/·J 0.. ~VI._... v....t,_. , I;.__;J..Q 1 :..,J-.,_,.._..._,... (,:..._,..! -•-·''·-· ..... ,]/•V-
berculosis, wh~le of 113 unvaccincted 18(15.9~) acouired it, 
thus re<iuci~1g the incidence to its fiftl-t. Co<~ttrols ;·ere sin:i-
lar n.onvc cc\.na, ted tu_berculin nege.ti ve persons enter:_ L:e 
Saskatchewan lnstitutio~s during t~e 5-year period Drevious. 
Ferguson found PCG thus to be en effective pro~hylact~c, but 
Eot absolute. 
Mal~ros(see 33) vaccinated 84 nur~es bet~ee~ 1933 and 
19 1'. -_', ' ' f ' 0 ., 1 ~- Pna ~as ouna nLy case o~ he.sled pleuritis c_=_,_ong 
theee. Pc:dne(llJ.6) has recently vaccine"teo ::urses r:t ''inette 
v!i th --::ocG, but the serles is not yet l2rce en.'JiJ.gh f;Jr deteil(;)d 
a::1!:' ly e.i s. :'ordl<rc:ll ( 111-1) used PCC vc..cc :nc tion fron 1936 to 
1942 in Stockholm on 205 tuberculin negative n~rses. b~ong 
this croup 1 case of probable mild pulmonsry tuberculosis 
occurr~d; of t~e 377 reectors there were 2 definite cesss of 
the disease, and 3 sus9ected cacEs. Rosenthal et al(l77),1948 
report a 7-year study on student nurses at Cook County ~osp~-. 
tal in Chicaco. Vaccin2ted stude~t nurses vere allo~ed to 
work in the tuberculosis ho29ltal, ~. ile control negative 
in t~e degree of exposure, none of the 142 veccinoted ~urses 
developed pulmonary tuberculosis,but 3 cases developed in 
199 controls c; ,c. 3 cases e;:oco:::1c; tuberc·.;liD p>Js:~ t.ive re2.c• ors. 
2. Kedical Students: 
Results from vaccination of ~Edic~l s~ude~ts have 
closely parallels~ t~ose found ~n nurs~s. Scheel of Oslo 
(160) reported his 0 1 se~v~tions ~rom 1926 to l9J5 8n 1,225 
before working on the tute~culosis services, 4.6~ de~elopcd 
tu~erculosis co~pared to 1.35~ in 262 Uantoux positives.Of 
295 negative reactors vaccinated with PCG, the ~or~ic~ ty w~s 
1. 95'ct. Lees ( 118) reports from the Uni versi l: .. '/ o:f Penns} 1 vE:~~ia 
an annual tuberculosis attack rate of 2.1 to 0.38~.Rosenttal 
(173) reviewed the literature and found an overall tubercula-
sis 
University of Illinois medical students have been 
offered BCG vaccination since 1939. Of 10? vaccinated over a ' 
four year period, there ';,·ere no cases of pul:nonary tuberculos~s 
corrrpared to four in t~Je nonvEcc in& tee. groups. (Rosenthal, 177) · 
Holm(97) hc.s reported on veccinetion of n6gative 
tuberculin rec:ctors among medical students a.t t:~e University 
of Copenhe.sen.Among 175 vc.ccinated students,no pulmonery 
changes developed during the exposed period of service, ··hile 
in 863 nonvaccinated negotive re2ctors 6% showed X-ray 
changes and 2.6f: had tubercle becilli in spu".:u:m or gastric 
lavase. Among 2,071 tuberculin positive stu.:3Er:ts 0.8~.:' sho1-:ed 
-30-
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'\ ' 3 . .American Indians: 
The effectiveness of control measures i~ ubercu-
losis can be uniquely studied at Indian reservations ~here 
the morbidity and mortalit~ from the 6tse22E is hi~h,where in-
comes are lo"fr, living co::1ditions poor. Since 1935 2. study has 
been conducted as the Gila River Reservat~on, Arizona, Wind 
River Reservation, V'lyoming, Turtle ~:oun tain Re cer'V~ tio:.-::, ~r. 
Dakota, Rosebud Reservation, s.rakota and in 12 co~Iunitie? of 
southeostern Aleske. Aronson and Pelmer et al(6,7,8) studied 
3007 persons ,ages 1-20 . .A random portion(l,s:;,o) of the nege.-
tive reactors to tuberculin(O.C0002 and O.OOSmg.P.P.t.) wEs 
vaccinrted intracutaneously with fresbly pre,ered vaccine. The 
remaining 1,457 were injected with 0.1 cc of physiologic sa-
line. :·'o change in 1 i vine condi tio.ns ltJC' s JYiE(e. Reexa:ni.nD. t:Lon 
at annuel intervals was made incl~ding tuberculin test, X-rays· 
and evaluation of tuberculous contacts. An analysis of the 




8,367 Person- yeers o:tfexpcrience 
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experiencE 
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Kore recently(l92) Aronson has sumsarized the results for the 
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=c.c=-=cc=iL==-c=c.~- ==-·-.=,-~~cc-==o===~-=="""--'-~~==-=~=~,==--=,- cccc .. ---,-=-=~=-c~~ ~ ten years(l93S-l94.S). 
' , 1 Yumber of reaths from all causes and from tubercu-
losis in BCG vaccinrti~n and control cases 
(192,p.97) 
Total 1936-1946 
Group: Number !-'umber deaths 
all causes 
:~:rumber dec: tr~s 
tuberculous 




nated 1550 55 6 49 
Control 1457 1C8 52 ~6 
It is seen trle.t the mortality from tu·oerculosis in t~le con-
trols was nine times greater than in the vaccinate~. 
4. Kiscellaneous Grouus 
P c·-'-' 1{1,.,.(7) uOS<:eDGDB 1 heve vaccinated 20 ~atien~s st a 
to one case of bilateral Eini~al 2rrested disecse in co~trols. 
Armies ln 1932.Savilahti(lE4) tuberculi~ tested 13,~00 Fin-
nish recruits during World War II. Co~parisor:. of th~ nor-
bioi ty of :!-~e 1,r.: cc inc: tee:: c:~H5_ nonve.ccin:-c te~::: s:ov-;ed tr~c t vacci- 1 
.netion ':rith -;:cG cave relative protection c;,ceinst tuberculos~s', 
5. ~esults in Scandinavie: 
I 
BCG vaccinEtion is well established in Scandinavia~ 
In fe.ct, it is U;e losical ansv;er to t:~e epi(s-:~io~.oe:icel situ--
stion t:et exists. A vigo~ous antituberculosis procrem has 
reduced tj,--:e tubGrculosi s -:,orteli ty fr,o;:: rrwre tLan 250/lCC, ooo:, 
population in 1900 to less t~&n 70/lOO,OCC in 1]44. 
lL a;. Denmark- BCG vaccinEtion -v.ras stc:Ttec, in 1927. Ti1e 
intracuta~eous method ~es introduced in 1930 and used 
extensively since 1940. Analysis has bGen restrictef to; 






t ee n obtai ned on t_ e i s l and of Bornn olm. Sin~ t be rculos is 
among c ttl e h - s t een erad ·cated f or abo .t 20 ye a r s the pe r -
ce tage of t uberc l in re ct : ons h s be en verJ lo~ in t he 
50 , 000 popu l ation . Cases of the d i sease were observed more 
of t en i n tuber culi n negatives , espe ci l l t hose tha t le f t t he 
i slapd f or short visits . Beg~ nning i n 1937 negative tube rc u-
l in r eactors leavin~ the island ere adv i sed t o ·nde r e o va cc i 
. 
"' ' nati on , and s i nce 1940 all tu bercul~ n nega t i ve ? e rsons re si -
d ' ng o· t e i sland ~ ave been ve.cc i L . ted . The me.jori t · of v ac -
c "nc;~ted subje c ts were i n the 15- 3S:·r . ge group . Over 10 , 000 
had been vaccina t ed up to the end of 1945 . mhe i ~c idence of 
new cases has droppe co .s i dera~ ly , espe ci l_y i n the 15- 35 
yr . ge group , a s shoKn by the graphs below. (from Kal mro s ,l28) . 
_ew C ~ ses of Pulmona r y t uberculos i s , by Age Gr oups , i n 
Bor nho _m ~enme.rk , 1936- 191+0 . 
~ .......,..,. ~- -
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still tube I'cul_n neg: e. t:. ve. The a: ount of i: fee ti on e:::J.countered 
varies in different localities, dep~n~Ln~ upon the ex~ent of 
has rise~ from 82 in 1934 to 4C,OCO in 1945(97). Recently 
all tuberculin negative reactors in tte ranish Army heve 
received it ~nd a campaign hes been launched for mass 3CG vac~ 
. t• Cl!:8_ lOTI of ell tuberculin negEti~e subjects bet·een ages of 
7-25, '·'i th fiDllormp examinE tions every fo'-1rtl: J·ee.r [;.:c re-
vacci~etions of negctives. All school ch~leren bct~een 10 ana, 
14 
The :ranisl1 Red Cross nm·r sends BCG teams consisting 
of a physician and two nurses to vaccin[te tubercul~:::J. ~ega-
tive subjects in different countries in Europe. tork has al-
the American and ?r~tish zones in Ger~a~y. A 50al of one wil-
lion vaccinations per month bas been set. (22). ~his enthu-
siasm represents the attitude of t~e majority of ranish inves~ 
tigators. 
b). ~·or";e.y -ECG- vaccin:?. tion has incree :ced in : ·o.cv.-ey from 
652 in 193E to 22,500 in 1)45. ~ertzberg re~orted(see 32) 
about 3000 ve.ccin.s tions up to 1945 2:, the Oslo ::unicip2l 
Clinic ~ith only 3E subse(uent cases of tuLerculosis. Co~pared 
to the nonvaccineted Oslo populrrt~on in l94G, th€ ratio wss 
1:5.6 for mortality, 1:10 for contagious zorbidity ~~6 1:4.3 







the E,046 persons exa~ined os comperea to 7E deeths/100,000 
populEtton in 194~.(32) 
Reference has elreedy bee~ mece -to ot1:s::- studiss mede 
va cci:::o ti on the ~-or"degic-_n Starting in rec. 1947, inspired by 
;:or'ltregian health 2'J_thori ties ,passed a lov.r providint;: for com-
pulsory vacci~rtion 2£ainet tuberculosis for tuberculin 
negative persons at the school-leaving age an~ for tuberculin 
negative army recruits, students, hospital stcffs and persons 
living in tuberculous hoses. (19,67) .The ultimate soel is to 
make the ve.ccination oclige.tory for t"::e tuberculin negative 
population between 15 End 5C years. 
c).Sweden:- ~uberculosis exacts a auota of more than 4,000 
- !' 
lives in Sweden every 2ear. The work of ~allcren and Andersot 
and Eelfrage has been considered. ~he number of vaccinstions 
in Sweden totaled 84,000 in 1944 and ~ore tha~ lOO,OOC in 
1945. 
Malmros has vaccinated 4C.3% of the ~2,000 population 
in Ore~_-ro,e.g. 15,543 chil6_ren and edul~s. Up to r'~erch 1946 
no deaths from tuberculosis had occurre6 ~~e no cose of )ro-
gressive pul~onary tuberculosis ~as reported a~iO~g the v2cci-
nated group.(l28). 
Tornell(see 33) has vaccineted 10,279 children 
and adults between 1934 and 1945 in 3ora2s(25~ of the 42,CCO 
populat1on). Until !~arch 1946 no ceaths fro11 tucerculosi s ~1a.d: 
-il==-=~-='-=-
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occurred among the vaccinetsd persons compared to 3 cases o~ 
beni£n a~d subseauent heeled t~b~rc~lous fiseE:c. 
since 1927. No control selection ~as prac~iced, but t~e tu-
berculosis de&t~ rate was more th~n four times tta~ of the 
rates in vacclnEted child e~. 
By Eoyal decree in 1944 tuberculin negative teachers 
are advised to undergo veccinrtioL. va~y of the netions 1 s 
inmates of ~ental hospitals, dentcl stu{ents, nsClcel stu-
dents, and tuberculin negative nurses are vacc~nrted. Sys-
tenEtic PCG vacclnction of t: c ~~ole pO)Ul[tlon of Gotland 
in conjunction with renewed X-ray survey of ltc isl2nd 1 s 
inhati tc-:;:cts ic. plE .• ::e<i. The vc:_ccir;e is of<erec~ t.o Ell con- 1 
scripts, Tuberculin neg2 ti ve ~1urses viho refuse Vf.'Cc LJc:.tio~-:: 
are seldom a.llo·.-ecJ. entrc::c:ce to ::.os)i tElf,, vrhere exposure to. 
infection is likely. 
d). ~est of Effectiveness of BBG: 
Aurehoej State School in renmark was the scene of 
ar. epidemic of tuberculosis in 19li2(97). ·,;,'he school had 
36E cirls ages 12-19 e~~ollee, o~ 
nated with BCG, 105 were tuberculin negEtive but ha6 not 
been vacci~ated. Ninety-four of the 105 were probably 
ex9osed to lnfection. Seventy beca~e tuberculin pos~tive, 
41 presented X-ray changes, a~d in 37 cases tubercle ba-
. - - . - - . " - - . !; Cll~l coula be de~o~str~tec. Slx cevelooea orocress~vs ~ul-~ 
..,_ ... '~ - :' 
mcnary tuberculosis, one 6ied. Source of ir;fec t jon wa.s -1-<o..ced. -td; 
' ··__;_._·-=-_::.:..-::.:z-:~-----:-=--==.------=- - ____ -- ___ ;:::_-- -=-=---·-·:.:. .. T:;:::::.._:...~-=::::......----;;;--== 
~.. ' ... .... 
COUNTRY 
Ar t;ent ine. 
Bel gium 
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ca.l me t te e lJ 
a.l(see 171) 
The ocros ( 204) I 
' 25-' 39 
Kraus , Lant;e 
{see 171 ) 
van den ers 11 
I 27 - ' 35 
Ar i zt. la t:u c>. 
(see 171) 
R~SULTS OF M.ANY BCG STU l EG I N PW!JANS TA LE 3 35a . 
(Y.odif i ed from Lev i ne Cl.T"id. . :> a cke t t ( 121) p . 51E) . 






PERSO JS VA CCirATED Morta l ity COI TROL S 
( Tuberculos ' s) Mort a l it i CONTROL SELECTI ON Tuber cu-
,.., . ., 
~.J '""'D '-' v v o . .l 
17, 976 childr en 
5 , 027 inf e.n t s 
8 .3% gener 
a J.tmorte l -
l y 
. . . . . . 
Tb4 ,l~2 persons 
... .. ... . 
38 chi l dren fol l owed 
by Carvalho 2 .. 110 
619 0 . 167~ 
20 , 000 infants : e de a ~hs 
Fo ll? w - ~p . on 793 l . l 3% va cc1na~ea , expos -
ed t o tb 
1005 pupil nur se s 
~:234 newbor n va cc . 
362 f ollowe6 , 72 ex-
posed to tb 
10 ,_ooo a t Bornho lm 
106 gilrs .. ~Aure~oe ~ 
schoo. , -
l , OCO , OOC chi l dr e n 
Children in 7 , ~41 
f ami lies 
203 
1 , 100 inf nts 
~uu 
5(one l os t) 
930 nev;born ; 225 
fol l owed , 55 exposed 




1. 9% (mor· 
bidit~ ) 
7., L~.oj 
~ . J / .. 
(' r:; o1 
' • :J;o 
l. l - 2 . 2J. 
0 . 6% 
0 
l. O% 
1062 newborn ; 225 f o l -
l owed , 55 exposed to 
t b 0 
2 ~ ~oo per s ons i n l~~5 , cbmpl e te fi g-
ur es avai l able 
501 nur ses 
Ra tio 
l : 5 . 6 nor-
t ality 
losis) 
Pot ava il_ g_ 1 ~ 6~ ( ~e · 
- ~ --' . / ' 6 ~ . -
bl e e r a l Tor 
f i gur es on tuber-
culo s i s mor talit· 
would be c or e h~ l n ­
fu l. tal i t y 
1 , 746 i nfan s .. . . . . Sl i gh t di ffere nce in mortal i t y fi guees in 
f avor of va ccina t ed 
ch i l dr en 








No t well ana l yzed 
3 . 1% Control s we ~e tube rcu -
l i n pos iti ve 
23death Exposure to t b not 
1 7d s ame fo r ea ch group 
- • ;o 
- s-· ( ;; . ;: mor- Finding s s :l.gnific an t . 
bi di ty ) Controls fr om pre-
v i ou s pe r iods . 
:No significant 
conc lusi ons 
Reduct i on of mor bid-
i ty t o one f: el f 
43 . 6% Effic ac y of vaccina- ~ 
morbidit~) ti on demons t r ated 
15 . 91 Compar i s on wi t h gene r -
al mor tali ty . Di agnosi s 
not often confirmed 
by necropsy 
Mortali ty reduced 2/3 
To t we l l con t r olled 
3 . 0% ate fi gure s i ncomplete 
No t avail able 2 . 7 - 8% General resul t s acc ep-




3 . 1- 6 . 25% Controls had tb con-
t ac ts 
Inconclus i ve 
Compared t o nonva cc . 
Oslo populati on 
I 
---
l 9~ 284 4 . 2% Controls wer e non- 1 ---~ · ~' /~vv ----+---~~---+--~~-+~~~~-r,~~~~~ 
re actors t o t uberculi r 









• ' · - - · ~ ··Sweden 
Birkhaug ~ jc:. 
' 37- ' 46 
Zeyla nd 8.Pic. -
se ck Zey l ::o.nc 
' 28-' 38 
(see l 2ID) 1 




Kleb anov , 
1 24- 1 40(1) 
Saye (see,. f2Gl) 
j 
l 
Wallgre n ( 22 lj 
Anderson&Belj. 
frage · (see 
32) 1 27 -' 39 
( c. :1almros l 2u 
I 
I 
10 , 000 i nf an t s 
anil ac1u lts : 8 , 046 follo wed 
0 
T2 ~1 3 5 vacci na te< 4 dea ths 
43b exposed to 0 . 91%) 
t o 
7 , 558 , 1156 not 
follo red ' 192 
exposed to tb 
133 , 877 chilciren 
1773 from tubercu 
:Ious f amilies 











ber no t g i ven 
78/lOO ,C OO Inadequa t e 
controls 
8 , 5% 
6 . 6% 
25 . 78% 
Contro l s were cases 
where vacc. wa s re-
f used 
General population 
compared H'L th follow' 
vacc n2ted gro up 
Control se l e c t ion metl 
od not gi ven , or contr c 
fro m heavily popul a tec 
area ; vaccinated were 
from 58 vil l ages 
8 , 200 childr en Birth-lyr 40 I .1. LJ- • c!'::J/o 6 . 22% 
4 . 0% 
3 . 42~~ 
controls Tram r· aml -
l i es with open tb 
where ls t. c: nd 2::~d c· ~ i 
di ed of t b . Numbers n 
compe r able 
1 '"' 69 _, . l ' . c .u cnJ. -. ur e n t,__ 3J3 exposed t o L.L 
1. ::, , 543 chi l dren 
nd adul ts 
3 . 78% 
l- 21 Y~E o/.:± • 2 ~ 1o 2- 3 yr s . O. "3 3 07~ 
OvEr 3 yr i:CO 
S arne 
age gr o ' s 
0 ~e ~ cases wh 
Co ntrol s were a few 
5 de t .. s c a ses i'lhere vacc . 
r efused 
0 
~e fused ve cc i 
n. a tion 
iTo t ava i lab e 
~+---11"~~· ;-,·,~~0--.-'l-~~--'--·-1? , l ~ ne\,; born _ 
('131) ,.27- I 3' l. 5% Con t rol s are nonvo cc . chileren of gene r a l 
nnnnl P ti n ~-, 
Sweden 
t- . I 







7 )' 1 34- 1 45 
:J - J I• 
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•( 177) I 36- 'LJ·C, 
Aronson&Po.l-
( r 1 9 ? ') me r o ,_ '- _ 
1 · ~ r:; ./.)() Levin~'8 s c:. ck - I! 
~~j ;Lif4-y I 
Bl anch e t a l 
- ( 35 ) I 30 - 1 45 
. 
Saenz ( s e e 





c:::;t"+ n~H corn ;--zr , o · r 1 death of 
oloc r childre n , ? meni nsl t t E 
~, 500 s choo l chi -
5P!en 
2\:1 ~xposed 
1)-+ 17 no neon tact 
151 contc: ct 
1 , 011 
103 , 202 bab i es 
14 , 146 nev:born 
5E2 exposed to b 
2 . 4% 
~ . 17 / l OOC 
0 
6 c e a ths 
( 0 . ~9'-1) 
1 0 of' . • (0 
7o1 I" 
1. 03% 
INo t ai:o a i lable 
Ge nera l i nf an ~_, 
populeti on 0 . 17-
_:one 
0 -J,o1 • ) L+/c 
84 exposed t D 11 . 9% 
t b 
l , LJ 14 non- l. 16 
con t act 
105 conte.c . 14 . 09 
Con trol s we re infan t s 
of general populeti on; 
1 va cc . ca ses ~ere sepu~ 
r at.An '\· mos n f' t. Pr> V ~' (' 
Contro l s vere too old 
f or va cc . . hen f i rst 
ob se r ved t c l inic 
Signifi can t re s ul t s 
1457 
1 , 073 
No t 
52 dea t hs 
None 
(2 -z r (., (JJ ) '/I..._, /i;_ • <-t 2 ;v _ 
• -1 ~ b· ' aV al _c:: l le 
c 1· p:, n :i. f' ' c !011" .:.. -re s ·' 1 .:.. s ~e~Git~ ~~~i~ob~I G ' 
Value of va cc ina t i on 









teacher. Of the 133 vrno l-~ed -.~een vaccineted, 106 were exposed 
to inf'ec tion, out onlJ' ti·ro s O'i·ied pul:::lo~E:c~' tutE.;rcul:::>s is. 
4 c&ses of diseRse occurred, ~ll ~ild. It is note( thct t~e 
prim2ry phenomena of the illness occurred exclusively in the 
previousJ_y t>J.bercuTi:c. negetive pup~ls, end L:. r.o instc:::ce 
among the ?CG-vacci~ete6. T~is is resarded as strong proof foJ 
the protective ~ole pl~yee by ECG vaccin~tio~ in preve:Jtl~g 
the morbid secuelae ensuing upon a primEry tuberculous infec-
tion. 
r. Evaluation of ~vide:c.ce: 
A summary of several important studies has been 
presented in Table 3 . From the p~rusal of numerous studies 
and an extensive review of t~e l~terature, a few facts are 
outstanding. ~hece are: 
1. DCG vaccinetion is h~rmless . Ad~~nistr: tion to 
over five million pEO)le 
sive diserse due to ~he 
sumpti ve evi6ence. 'orld opinion here is una.ni-
mous. 





is unsatisfactory, because of th~l 
q 
:'CG- in:fsctio~, leek of contY<ol e.r~tl 
!: 
difficulty of separating s,ecific from nonspecific f, 
il 
factors. Powever, there is little doubt that va~r 
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ted inf~nts in the SE~e communities. 
~· ~he s~cller, better co~~rolled series bEsed on p2renterel 
injection yields conclusions in f~vor of ECG in the 
greater number of st~diEs. 
:: 
4. Years of' system2 .. tic and complete observe; tion of ~;roups o:f 
pupil nurses, mec_icel students, Ar:1sr·l.car: Indiens 2r:d 
other Ero~ps show that a)the risk of develonin~ tuber-
...... \,_..f 
culous disease is greeter ir1 nonreactors thEn in already in-
a.~ 
fected tuberculin reectors :n the countr::.es studied,J2) among 
nonreactors vaccinPted w~th BCG, such disePse has been re-
duced to a level approaching a~d in so~e cases loYer ttan 
that of t~e re~ctor group. 
V.PROBLEMS ATTEI,TING ?CG i.'ACCPTA'ri0N 
A. Return to Virulence: 
It is of para:rr.ount inportonce to escertain whether i 
BCG will ever regain virulence and if so, under 1·:bi ch condi tio.ns 
this is likely. BCG has been found immunologically to have a 
tuberculosenic principle similar to thet posssssed by virulent 
bovine and human bacil:' 
in tuberculiD reaction uhen 
ii 
Birkhl3.ug(26) found no clifferen~~ 
q 
Br:r: uj~,-(- 0"(' Po,. '1.' ·:-:e 111 T~ 1' ec.. II "-'ere ii \_,""" ' ~- - ·•-· 1/ ... ,o. \i c.,_ .L \_..o IT ~~ 
used. M2ximum protect~ve value is only to be e::pected from tht 
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WPS to be 2~ticenic2lly r~l2ted to 
E:~ovir..e C 2nd ~., 37 by Tc'udd o :·.a Furth ( 130) . 
1. Retur~ to Virulence in Anim2ls 




: is e "virus fixe". :'n 1933 he \·.•rote" .•. :r?CG, e.s :_ t :_s used for 
infants e:·d bovine vacc l::e 1.l on, is a fixed, 2 t tc1ua tEe virus, 
! causir..c al~ays t~e sa~e curable lesions ~tich · t is imposs\~le 
to reproduce by c.nir:;cl pB.SE2[eS ••. 't has rh•rys t!.:E Se.me CUl-
tural cllerDcte:r:l.sEcs, e_~c' t!·:e same ep~ituce to i:::nru::J.ize the 
i' 
receD -;-l·ve or·-~-r'-i sm 2r.'"'~ . ..,0-'- '.r·_rule_,.·lt .... ,-·J6l"'l·r··-Pe·cti o,~c::_:: (r::··:;' '1'·',-,l· s 'i !! i ..... . t .......... 1 _ ... ~ . c:.c- _l ... ~.~ L o ........ . _ 1-~.., '...} .. _l _ • __ , . ..r • _,_..... .I 
.. ii 
:1 was a. rei ter,~tion of 2n earlier st[·'·emen": ·.: i.ch hrc' :een suppor...: 
l ted by Kraus(l20) 2nd Schroetter(l26) since t~c chences pro-
!i 
'i duced in 2ni.mals tended to locelize a~·ld retrogress. Vuch co::1-
troversy erose among tuberculosis 1-nrkers on t:lis ))' ___ t. 
Opponents of BCG have contended thPt t_e culture is 
not ent'Lrely avirulent, the:'t unknovm con('itions f'VOI' ltE v:.ru-
in gui~ce pic~ 8r rab its, by dissociation or by ~thods of 
culture. A surns2ry on t~e ~ethods end experiments for inquiry 
into t~~2 ~ubject rre prerented in ~able 4. Inver~icrtors 
attempting to conflrm evidence of incrense~ v~rulence have 
either been unsucces~ful or hEve obt2ined equivoccl re~~lts. 
Animal pasrase e~peri~ents heve pro~ucee only a few unimpres-
sive result.s. Petroff has recently COLC8c~cC. (171) ::hrt tte 
present ECG culture i~ probably a pure R form, 2ne £s such, 




\'! ORKER YEAR 
Petroff et a l 
( 155) ' (156 ) 
(150 , 1 5 1) 
Nobe l a n So l e 
( s e e 1 5 1 ) 
Watson ( see 151 
1925 
Petroff e t a l 1927 
~ormaeche 
( s&e 59) 
/ 
Dr ever a nd 
Vo l lum(75 ) 
Much (see 59) 
Sa san o and 
.e d l e r(l95 ) 
Seiffert(l9 
Fe l dma n( 79 , e0 ) 
1 931 






nim a l passag e 
A~:i nal pets sage 
( 
3€a . 
Ino c ul t ion of 0 . 25 cc . CGII and s• b-
i noc u l tio , af t e r whi c h oorti n o f ~i Beas d . n od@ i no c ulate d ~nto anothe r BUlnea plg . u O .e anlma~s devel oped 
procr es s i ve t b ; cla im d o roducti on 
o f n " b y 5 pe.sso.ges ·n a n i mals . 
Inc ~e e sed v : r u le n c e 
!I !I / 
DI S?OCIATrON - t riture tion of c u l t r e . fro~ Cal me t te 1/ i n sal t solutior: , f il t r ed through :lh~ tman p ~.pe r#5 , the r . 
5 d rops filtrate s me red ove r surface of g e ·. t ian - vi o- 1 
l et en; medi · m. 
Resul t s : 2 types co l onies , Smooth and Ro ugh i n r atio 
1: 15 , 000 . Ro t.gh co l ony wo.s \·;ax y , c l ee.r - c ut o • otlL~~s : _ 
not exte ~d i n~ i n t o mcdiu~ , ~o e d~f ficult ly emuls lf~eo . 
Smoo th c o l ony s m2ll , irregu l c r wr i n. l cs , t ti~es ex -
t ended into me dium, mo re read: y e nul sified . Subcuta-
neous i n ocula tion i .. to aniL~ l s of l. tter Eave prog r es -( . . \ s · "l ~ r ar'lr;·inis J.r sive tube rc ulosis i n r..;, .1 ne .... P - £ S; . · 1m1 b. LU.U ~ · ~ 
tion of Rough colony 8ave les~ons wi t h te rrd nc y to heal 
and disapp 2 r afte r 2- 4 ~ont . s . 
As s oc ic:tion o f 
BCG vri t h Strept . 
c a v iae 
Dee p b ouillon 
sub c ult• r es 
Cul Uv tion in 
med i a c on t a i ning 
l a ctic a c id 
Gro 1t h on Sau on ' s 
me d i r. , P-" 7 . 2 - 7 . 4 
1iuh 10% unhe c: ted 
r .bbit ' s se rum 
Su b c u lture on b il -
f r ee media 
Increased v irul e n c e . Results 
could not be re.rod u ced . 
Generalized t uberc ulosis i. 28 
g ui nea pigs inoculcted intr~p rito -
neally ~ith 0 . 1 - 20 mg ~ Sever~ p rog res 
sive tub e rc u lo s i s i n 12 r c.b'tn ts · 
i no cul a ted i nt r ave nousl · ·ti t h 5 - 50mg 
Incre ased v~ ru lence 
Rebb i ts s h owed e x t ensive tuberculo 
i s 
4 vari .n t s found : s tri chform , 
heubacil l e nfor~ , f l ~che k 6r n -
c h e nform, hoh e hau fc h nforrn 
~ub c u _ ture on ~ l y c er­
i ne egg med ium- 15 gen-
e r at ions 
Of 58 g ui ne piss , 1 d i ed of t b . 
Of 6 r abbi ts , 1 died o f b , othe r 
5 s h owe d . 1 s~ ons . Pcs sage attempts 
f ailed . Con c l de d t h n t BCG ma y 3 t 
times p r oouce numerou s a nd e xte n -
si v e tubercle - l ike - ~clons . 
ATTEMPTS TO CO NFI RM R~PORTED I NCREJSED VIRULENCE OF BCG 
WORKER 
Ca ' met te 
(57, 59 , 60 ) 
Kr aus ( ll3, 
114 ) 
Gerla ch(84). 
lzal kani ( 1 27) 
Rosentha l 
(174 , 175 ,1Ji6 ): 
Park et a l (14E) 
.-' 
Ro senthal ( 176 ) 
Rosenthal(l75) 
Sullivan ( 20l, 
Shaffe r(l93) 
Neuf'e l d( l 36) 
Frimod t- r:uller 
~ 86 ) 
Se.enz &Co s ti 1 
( 172 ) 
Boquet(37 , 38 ) 
/ 
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HETHOD USED ?·SULTS 
Col lected c ases of spon t aneous tube rc u l o sis in a n i -
ma l e in l i teratur a nd suggested t hc t it is more com-
mon t han supppsed . Suggeste~ t ha t Pe troff ' s work no t 
free from e xpe r imenta l errors . 
Tes ted Pe trof f ' s R R did not c ause prog r es sive 
and S v ariants . t ub e rculosis i n ' guinea pigs;S 
was p2th ogeni c for g u inea pigs 
Nume rou s expe r iment s Inc r ease i n pa t h ogeni c ity of 
on gu i nea pigs , r a tbi ts , BCG never ob s e rved . 
~ ;gats , h orses with 
Pe t roff's cultures 
Vi rule nce of unmodi - . 
f ied BCG te sted on 28 
g uine a p i gs , 18 r ebb i ts 
De pe ndi ng on degree o f resis-
tan c e mE tl BCG either d isap -
p.ears fro rfl s y s tem or le ad s to 
n r oc r <r:ssive t b . 
Injection of BCG i n l arg~ · Jo prog re ssive t b from 
doses in t r a c a r dially , these i n jecti on s. 
intraperitoneal ly , i n t ra-
c u t ane ous, oubc utane o u s 
Repetit i on o f Petroff ' s 
work on thou s ands of 
guinea ~igs a nd rabbits 
Repeti tion of Petroff's 
, .. vork 
Incre a se o f virule n ce not 
de~o ns tra ted . Vari e tions in 
morphology o ccur , are tran-
sitory , revert to usua l fo rm 
aft~ r 1 or mo r e subcul t ures . 
Incre ase of virulence not 
d e monstr ate d su c cessfu l ly 
i n gu i nee. p igs . 
Addi t i on o f c r u e BCG 
ph os pho li p i ns , e gg l e ci-
thin o r cho l esterol t o -
No increase i n virule n c e upon 
ani ma l inoc ul a t ion . 
media 
Reoe t i t ion o f Dreyer and 
Vo J. ium' s 1·10rk 
No increase in virulence on 
a n i ma l i nocul a t ion. 
Unsucce ssful repetition of r r eye r and Vo l l um 's. 
a l s o ac c 6m) l iched bj Saenz , Gerla c h , Calme t te , 
vmrk 
v an 
d e n Berc;h . 
BCG c ultur es on auton's . 
medium , on Petroff ' s medium 
'T'e ""e , ·t' · e , · ~ SG a g ro w n on egg m ~ o l a 
pH 6 .1-7 . 8 , addit ion of 
horse , o x , r a bbit , sheep 
s era . Repeated Sa s a no&Med-
l a r's e~~eri~ent . Cu l tu r ed 
2 str a i ns from Dr eyer a : d 
Vol lum on Petro f f ' s medium 
Ex am i ne d P~troff 'e cul t ure s 
Repea t ed Petroff's expe r i -
me nts 
St ud i ed d is so c iated forms of 
BCG f or 3 years 
Repea ted Sas ano and Medla r's 
work using a dos e 10 - 1 5 t i mes 
g beate r than t hey used . 
Isol a ted the ~us and org ans 
o f guinea pig inf e cted w~ th 
BCG , c rried t his t hrough 4 
p a ssages in guine a pi g 
BCG wa s co n s tantly aviru-
l en t. Ind r ee s e in v i rule n-
ce a f te~ 3rd pas&ase in 
r abb its unsuc cessfu l. 
No S forms p roduc ed with 
i n creased viru lence. From 
Dr eve r and Vollum's cul-
ture s S colonies pro -
d u ced, moderatel y viru-
lent fo r gu ine a pi g s , 
le ss so f or r a : tit s 
Both R and S fo und 
vi rulen t and o f h uma n 
type 
No change fo und in mode 
of g ro wth or v i rulence 
of _CG 
Vari ant3 d i d no t pro-
d uce t ube rculo us l e s i ons 
in suscept i b le a n i ma l s 
No si gns othe r t han loc~ 
lized l e si on , s ligh t 
swel l ing of l ymph nodes 
a s us ua l ly c ause d b y 
BCG. 
No r etur n to viru-
le n c e 
r 





! ~ il 
tuberc~losis,Coulaud(?O) has injected up to 1~ intrcve-
nously in re~bits,Saenz has i~jected up to 7CC mz. subcuta-
neously in gui~eR plgs,and ~emlinger and ~ailly(l65) have 
inj ectec up to lGm. subcu tc.~:eously in ro.b2i + s "'-Ji ti2ou t deve 1op~i 
ment of p:"o0::ress .. ve tuberculosis or dE:e: th fro;;: sLack. r-~ov1ever ,: 
ii 
,• 
a few observers have felt that in ths early e~periTents the 
animals were killed too soon to s~ ow tLe developem~nt of 
di sec:.se. 
2. Return to Virulence in Man 
The incident which has done n~st to damage the reputation
1 
of BCG v·e s that , ·;·,:1_ ch occur:i."'ed in Lubeck in 1929. \"ace ::..ne 
a strEdn o'f:CLin.ed fror.n. the PE.steur Institute ir. Parls l'rc- s ad-
of t~e su ~ects developec acute tuberculosis durinE the ~eYt 
fev-; weBks end died. The death toll ree.ched 77(203). LLont;:e 
(115,116) rrc::.s sc;nt to :ubeck by ti-:.e 2-erme.n Reichs;:_;esunc_iJ.eitc:am:t 
;I 
tc mai:e investit_~etions. Appe.rently ti1e FCG v,rcs of 2ttenuated 
virulence, because t~e same strain bed been ci~en to 573 
children in Frence, e.:Jd hEd beer: use6 for vc>cc::.;-:.:: tion in !.e:t';ic~ 
-1 
and ~iga wlth no untoYErd results(lll). 1,; 
After the fourth child had died in Lubeck,Prof.reycke, 
head of t,>e le.boretory, destroyed .sll t>s rerJe.ini~::.£ vc=ccir_e 
and availa~le subculturEs, ~eking inveetieEtlo~ 6iff cult. 
Postmortem exaiinations bn veccinated subjects (20:,187) s~oye4 
·I l ~ involvement of t~e intestine, Yith numerous ulcers end stric- :! 
li 
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kidneys c,.::.d lun:_ s. 
Cultures fr~m organs of infants wio jed diec after t~e 
BCG inocule tion s"owed virulent end .r:onYirulent :_sc teric ( 111, 
136) .Sirr.ilar bacteria YE::r'e ct:::.':u:."ed fro:~: resicue.l v:.cci":.e.tion 
material. At the time there wcs one other culture in t~s lab-' 
oratory, a virulent human type isolcted from a child with 
hip joint disease, obtained from Kiel. ~he Kiel strain e.~d 
the culturei from orsens of subjects geve a sree~ discolora-
tion on Sauton's medium, 
The testimony of experts e.t the triel hPs been repor-
ted by EaLn(93) and Ke.yne(l05). J'ost of them held that a mu-
tation was possible, but in t~is case, highly im'Jrobe~.::le. Sev..J 
- ' 
eral chatacteristics of the bacilli fros ~eae 
changing virulence, lipoid content, peculiar Erowth an~ color·-
tion of ':i::.e culture v·rere used a.s arguments for conte.rllinc: tion 
wl th tree Kiel strein. rr. reycke ~--as se:ctenced to ti·-'O yeers 
in prison; rr. Altstaedt,the city teelth officer, wee sentenc~d 
to a 15-rnonth ter:n, but the laboratory ascistu:::t, :·iss Lnna 
Schutze w2s exonerate~. 
U j pest, :.::ung:ry 't!B.S e e scene of cL;o ther "inciC.ent" 
w~th BCG. Tuberculous cavitat~on and dePth wes re)orted in 
3 of 12 vaccinated infants. Careful inve~tigEtion s~o~e( th2t 
only one casE wcs autopcied, and t~o werE ex;ose6 to ~~o~~ tu-' 
berculosis 2fter veccin£t~on.(see ltl). AriztiE, Ore:~ana dnd 
tel-Rio in Chile(3) found tuberculous les~ons at 2utopsy in 
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I. but the se:1rr:e ettendant cereC. for :;o nonvaccLJ~- teo iLfa:;.ts of' 
vrhorr. r:one deve"2.opec tuberculosi.::~. This ir.cirJent ·l_s 2-'~'f~pic:l.ous, 
~ut t~e possibility of infect~on ir: ho~es before hospitalize~ 
tion Wfs not completely ruled out. 
Jaso(lll) reportPd C:~- caPe Oin C'Vl"t~Ll·o~- ~~(~ rc~er~1~~ed 
- - C- t<_. L ...... C.l.:_t (.:,...._....!..!. (.;.~...__._ LJ ,• 
tuberculosis l."' .u. a child of 13, but taere wcs probab~y a pre-
existing lo'\v grade tuberc:.Jlosis infecti-:::1. Blechman(36) a.nd 
Bacigalupi(ll) report cases of infante ~~o Yere vcccinPted 
but s~ccumbed later after exposure to virulent infection. ~his 
does not detract from the value of vaccinction for its protec~ 
tion is not declared to be absolute, ~ut rElative. 
~ueno(42) reports that Aseis ~es E(miniEtered u~ to 2C 
centigrr8s of ECG to adults wi·hout unfavorable resuJ~s. ~o 
non-allergic c~ildren he has ad~tr:istered ~&ily 6ooes of 2 
centirrfms to c~ to-::c:l of 0.96-1.32 Gm. lm experiment mece 
himself, injectirg 2 Gm.BCG-, gave no unto·,'erd rE-2Ul':s. 
KEl"'t:szturi and Ferk(lG7)f'ound in 2'T cases thFt ~:.e virule.nce 
of ECG streins recovered from cold Etscesses caussd by vrcc~-
nation coulc' not be s ,O'i.'Il :o have teen er:cheY.i.CEC: :::::y l:':..vinc ~n 
the human body for pertoC:s ~f 1-lC months. Carper et al(6E) 
concluded that ECG does not ryroduce procressive les~ons V8en 
injected intr.scut::t:eo~J.Ely 'Ln man a:-~d ':'_en injectec ~L c:~:::)·;nts;: 
capable o~ cr~si~g tubercles without ulcerEtion(G.Ol mg.) the_ 
orsanisms lose their viability in + •ese lesions wit~in abo~t 
6 months. 
Jensen(lC4) assessed the virulence of his ECG strcin~ 
!; 
intracutaneo~sly into guinea 1 
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..., pie:s anet observing the exa.c t durB. tion of e ech :wouls proCit;,ceC!. 
Jensen's report in 1946 is the first one in several years 
that baa implied Be chnnt:ing virulene:e fa:::-' ECG. Ee compared 
ECG 1 and ECG 423 a~d thought that the former ~~s much more 
virulent than the latter not only because of an R-S disso-
ciation pLer:tomenon, ~>:;ut r:.lso ~:;ecause of contlnued bile-po-
t~to transfer which increased tje virulence of t~e s~rai~. 
Be stated thPt repeated transfer on Sauton's mediu~ over a 
long period of ti_e resulted in sraducl decrease in virulence 
d:.ue to tLe presence of am::c1onio-ferric c':. trate vThich unde-rgoes 
chemical change in the presence of moisture. He also found 
that sxall aGounts of copper in t: e 6istilled water affected 
the virulence. He advised that the best way to keep t~e vacc~i 
l 
ine at an optimal level was to zrow ECG on Sauton medium and 
interpose so:r:J.e bile pesE.;eges 1-;hen t:~e virulence becins to 
decrease. ~e note that this is the recommended met~o6 as 
described earlier and that if the instructions are f~llo~ed 
and the vnccine prepared correctly there is l~~tle d2nger 
of greatly increased virulence. 
Lumhol t ( 125) has repo:::··ted in 1946 perhaps t.he first 
instance of lupus vulgaris developm<::nt on ";_·e ·:csis of :SCG 
vaccination. A 16 year old work~an wrs fiven en injection 
of BCG over the left deltoid on March 4, l9h3. Shortly after, 
ulceration develope6, and s;read slowly 6~rlng t~e follo~:i~g 
six months. The Kantoux test wes weakly )~sitive to O.Gl ~E· 
1 . ' t , - t• - . -1- • "'' 'i Finser1 1e:ht trec: -c.men ·s c.Lee.rec; up ·::_e: conc.1 "_o,:~. ·.·ne respon-:i 
'I 











The report does not a6equetely ~escribe t e sethod of prcpera-
tion of the ve.ccine or t::e E'Jount of' ex:posure the subject 
received to tuberculosis after ~accinetion. 
Irvi~e(lOl) hes reviewed t~e literature on re-
turn to virulence of ~CG very carefully. ~e concluded in 1933 
thEt even if every purpo~ted case of increased virulence were 
substantieted the incidence age.inst tote_l num1:;er inocu::C.~ ted 
would have been just under 1 in 15,000. Authorities all over 
the world have aereed that medical literature fails to reveal 
any proved cases of pro[ressive disease as e result of PCG 
vaccination. Eovmver, t!1ere ere S01'16 observers 'dho remain 
doubtful because BCG is a li~e vacci~e, an6 they are unwilline 
to exclude return to virulence as a possibility. At present, 
however, th~s seems very unlikely. 
B. Comoarison with Other Veccinetion Vet~o~s: 
1. Vole Bacillus 
the Vniversity of Oxford 1937 Wells (226) 
I 











tis) which closelv resemblee tuberculosis. Cultures from coseods 
lesions sowed acid-fast bacilli of 2 new t:pe. 
lerce doses(l.0-0.1 mg.) injectee intravenously i:: to 
or intrapcrito~ealJy into EUi~ea :p~fS ]rofuced te~th from 
acute miliary tuberculosis in t e forffier, de~th fro2 acute 
or st:'picel c>ronic tuberculosis i_::-1 t~'le l<·ttr:.r. Extens~_ve 
exoeri0ents have been mPde by seyeral wo~kcrs, includi~g 
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one group, BCG to ~~1other, fol~owed by infection with v_ruient I . 
tubercle bacilli 1 t~berculosi~ ~as severe in Ell t~e i~~unized 
\ ~Ld non-immun: zec f;uinea plfs. The effect. of :L:; uni zetion ,,,e s 
siDply to delay tl1~ prosress of tuberculosis. E':i.rkhaug 
! 
i 
concluded (31) th~~ intravenous vacci~~ tion of ~ulree piss 
~ith vole 2ci6-fan~ beci~lus(Wells) ~rior to infection with 
virulent hu22n tubetcle bacilli, gives a hiGh cesree of pro- , 




/6-c 'foo Soo 6oo 
Survival time of \Ole bacillus im2unized ~ro~D TT 
immunized 1-=':rouiJ I'I ....... ,:: con"'"ro~ t. 1 '-- ·- ____ , T::CG ~- '- ·- 0 ""U l l> ..!.. UDerCU-OUS , n . • 
· 1 (l . ~::rcct1onrv an1ma s 2 animals in each ~rouo. 
,_ -
Young ar::.d P;; terson( 2:::.8) founc1 1,,,1· des'"'_, re'"'a~ ..... be - 1 
, <.J o 0U, rcu1ol 
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6.1 ~g. and 0.01 me. of vole bacillus strain G564 i~travenously. 
They issue a warning concerninE t: s virulence of some strei2s 
and suggest further study tefore fi~al conclusio~s are ma5e. 
?irkhaue; ( 31) he s v.s ccL~[c ted lt tui:erculin nee: a ti ve 
patients et the ~eevencaar6en Insane Asylum at ?erzen with 
a 5 me:/rll. vole be.cillus suspension by t e ~1ultiple puncture 
method. He found more permanent vaccinetion mar~s produced 
a2d a stronger tu~erculin reaction t~2n [ivcn wi~h BCG,sug-
gesting a lesser marsin of safety and greater virulence then 
v-Ii t1J. BCG. 
The vole bacillus has t~e adva;tage t~st it :s not a 
netural parasite of man or c~ttle. mhere is no need for artl-
flcial reduction of its virulence ,at leas~, so far as can be 
told at present. Is the organism acquiring greater prthogen-
icity when removed from its natural host? ThE discre)ancy 
found between t~e virulence of early, recently isolated 
strEins and later subculture6 strains ~ake t~is conclusion a 
possibillty(4l). uo~ever, ~e must wait for the results of 
experiments now i~ progress before definite conclusions are 
in order. 
2. Feat-Killed Bacilli 
Langers(see 153 ) va,ccineteO. 34 chilc5ren vrith 
heat-killed organisms.After 4 years 33 were free of tubercula-, 
sis. Soper et al(l96) found that rebbits vaccinated with heat- 1 
killed S tubercle bacilli survived longer than those given 





!Ill : too me.ny enirr:als survived t:_e: e;c'Jerit~E::~ t ce::t 
."1 I -
the compere ti ve survival peri_ o6s of t;,e cE fferc; t gro!-'~Js. It 
is generPlly believed thct heBt-kille( bac'~li [iVe 2 decree of 
protection, but this is trrrsitory and ina~eoufte. 
3. Salvioli's vaccine 
of 15 years' use in Italy of "Petragneni-Srlvioli's vcccina-
tior:t by infection"-. Ir;oculr tion 'r!3. th formelc1el yce-tillecS "yeo-
tacteriu8 tu~erculosis is performed on t e sL~n in four pl~ces. 
Yantoux tests, performed 7 years ~fter vEc~in~tian, ~ere positive 
in 90'~ of 5,700 infents. V.s.ccinctec subjects fen· w~~oir: controls 
were available at 7 ysars a o~sc a lower ~ort~lity th~n the 
avere;::e morteli ty 2 t t::i s a.re in tts c 4. ty of Polocne. Profs seor, 
Salvioli conte~ds thrt tte killed vacciLe is Gore active, is 
nonperishable, abolishes the local lesions at·(~drnt u,on BCG 
vaccination and st2tss thEt results of his experime~ts sur-
pass those w~th ~CG. The report(214) is a preliminary o~e o~d 
detailed analysis is not poss~ble until full rEsults ere pub-
lished in the medical literr~ure. ?owever, ¥8 cDn point out 
here thaticomparison of ~ortrlity rates ~~ th t~6 ever~~e zor-
tality rate i~ tte population ca~ts so~c eoubt on tte s~5nlfi-
cance of the results. 
4.Ultraviolet-irredi~ted Vaccine 
Olson, uobel an6 Piggott(l44) hcve founf tnat a killed 
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~ ' of e. virulent tubercle beciJ lus ( s trc::in 19S-RB) ~;,:_ th -- •. ---· --- -~·;---.. :::-=-~~~....;_ t:e Cm;en-
he irner-LevL~so> eppe.r2 tus, ac'rnini s tered ir1 3 dose E w:- s e cuelJ.y 
as effective as o~e 6ose of RCG end ~ore effective t: 2n 3 doses, 
of BCG against virulent l~fection in cuinea p~gs. ~hey steted 
the~ the ultrPvioJ.et-kille~ bPcilli of t~e virulent s~r2in 
virulent strain teet-killed or ultre.violet-kille~ ~CG. FurthEr 
study is ~eing mkde to determine its effectiveness ecainst 
heterologous virulent strai~8. 
Because more work has been done with ~CG than with 
any other vaccine, an6 consequently more is known about it, 
more conclusions can be drewn about its use t~an a~out t~ese 
other vcwcin6s. Until 'i'e kno1r1 more r1.::out the value of other 
vaccines egeinst tuberculosis, it seems tet~er to use :CG w~il~ 
continuing experiments upon it and experiments in t~e search 
for the perfect imnunizing agent. 
C. ruretion of Immunity: 
Another problem which must ~e consi6ere~ is the 
length of time during which PCG will g~ve reletive protection. 
Some euthors think thFt immunity re:neir:s es lone: c.s t!1e tuber-
culin tEst is po2 _ t ;_ ve, o thcrs t:~ink that tuberculj.L eenr: ~ t=.. v-;' 
ity and immunity ere not releted en{ th2t iiiUnity persists 
in spite of loss of tuberculin sE~s~tivit~. ~el1Eren(222) 
thinks t:na t it is s2 fer to coLclucSe the t i r=muni ty di sap~)e;::rs 
wl1en tuberculin se~s~tivity disappears. Sometime~ the tubercu~ 
11~ test becomes negative in 2 couple of years or less; so~e-




U;E longer Le Eens:itivl_ty lasts, the r:o.0re likely it i:.; tl:c:t 
a semi-permanent tucerculin scnsltlv~ty a~d ~sTunity bPs re-
Although there is no rcl~Eble Eethod of d~fferc~tiatin[ tuber-· 
culin sensitivity produced by BCG fr~m thEt produced ~y " " . t"C_Cl-
tionEl virulent infection, that from te former is UfualJy 
slighter, and often requires 1 me. o~ tuberculin to cause a 
positive reaction. 
There is no precise deta on the question of duration of 
immunity. Calmette end his conte~porcries gave 11 as a maxi-
mum of 2-4 years, and in animal experiments it has usually 
been less. Calmette sugsested that children should be revacc~-
nated L.i. ticeir fifth, seventh, a;.c.d fifteE:ntli ;;-ecru. Recent 
series from ~orway end Sweden suggest th2t wlth l~proved 
methods of ep:Jlicetion t:1e c_~Jretion of ~rr.cun·L ty(by L!ference 
from that of allergy) ~ay be 5-6 years or more. 
Rosenthal(l77) founc Utot in 1,417 vacc.lLEted chUC.ren 
the tuberculin recction re~sined positive in over 9C~ up to 
4 yecrs, an6 in about EO~ after 6 to 6i years followi~G a 
single vacclnction. Ve~re B"d Eretey(l32) investigated the 
durc tio::. of cllergy r:fter veccin[Otion by t: e sccy··~f~cction 
me thoc5 in children of 3 to 7 :·er:rs of ace and in the: eoul t 
inmates of a me~-~ tel asylum. ':'hey found t::ce t tuberculin e.ensi-
tivity disappeared in 2~ to 3~ years. Aronson a~d Pel~er's 
'Ork(l~2) showed t~at 92~ of 669 subjects retested in 1946 
were still tuberculin poettive althouEh t~ ey were first VRcci~ 
II 
nated 11 years esrlier;54~ of 614 controls were uositive. 
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Fro~ the r~ports in the llterature it woulf seem advisable 
to revaccin2te every 3-5 yrs., or when the tuberculin test 
after once )Ositive reverts to negotive. 
D. Other Problems: 
1. Some observers(227) have objected to the usc of BCG 
V['~Ccine tion on t- e :_ :·ouVlis t~e t it would interfere i'ii: h the 
diagnostic value of the tuberculin test. Per:::ons recently in-
fected,i.e. after ECG vaccination, could noc be detected by 
this means. If Lt is accepted thet BCG does give relative ~ro-
taction and is of def-~ni te value,autr1ori. ties :nust be ':,;illing to' 
sacrifice U1e tuberculin test in vierJ of tr,e imGuni ty gained. 
2. In certain cou~tries, notably Greece and Drazil, 
there is prejudice on the part of parents against Lnocul2tion 
methods. This hes led to greater use of the oral method,a method 
!: 
which produces tu~erculin sensitivity in a small{f-7) percent 
of the cases. However, Assis discredits this, contending that 
latent allergy or infratuberculin allergy is produced. (see 42). 
Individuals who ·do not react to tubercul ~-!1, ap_)B ren tly non-allerl-
gic, have a considerably s~ortened period of pre-eller~y when 
reinoculeted. We can argue here that the uncertainty of the de-
velopment of this infratuberculin 2llergy makes lt seem unwise 
i: to rely upon this v.rhen tuberculin sensitivity c<:mnot be demons trn-
li ted. Instead, education of t:,e public should be undertaken in 
i tLose countries ~.''here U:is problec is encountered 20 t:net public 
II 
i! opinion m2.v be persuaded to fevor ~erenterel Gnc transcut&Ileous i; i! ~ ~ " 
i! 
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3. lt.'ould pErents submit to havinE tfie]_r children inocula-
ted age. in a.fter they hed undergone the reguler irr::::;mn.i Zec tions 
against diphtheria., smellpox, and per"cussis? Some vJOrkers be-
lieve thet it would be hard to convince p2rents of its effec-
tivenees. On the other hand, in countries v;here tllis has been 
extensively used, this problem hes not been encountered. In 
Scandinavia, parents seldom refuse ECG vaccin2t~o~. 
Reference has elready been made to the wide use of 
BCG in J:-rorvmy, Srreden, r-enmark, Cana.da, Russia, Greece, France 
ancl South AmericH. The Sce.ndinavian countries are employing 
mass BCG vaccin?tion and are offering it to the European coun-
tries, as cited before and reported by ~olm{229). ~orway now 
has compulsory BCG vcccinatio~. In Parasuay(E7,8E) chest X-rays 
are obligatory for all putlic officials, public and private em-
ployees, teachers, st~dents, a~d peo~le fbaut to travel. ECG is 
given to negat~?e tuberculin reactors. Countries wh~ch heve 
heretofore been silent on t~e question of ECG vaccinetion are 
now reconsidering and undertaking experiments to ascertain its 
i! value. 
II I ~ 
li I; 
I' 
11 in the 
==-- --=-"~----
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Two cases in point are the situetion in Eritain a~d 
United StE te s •. Calme t te repea tedl;y advoca. ted use of BCG 
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in Britain. Irvine ( 101) also recomr::endec i_ t. ?he attitude of 
Ninistry of ~~ee.l th hos been t:-~,o:·t vi1~oroGs ~;u1.:;.1ic he&.l tL con-
trol measures would accomplish results commensurate with 
those obtained fro;r. BCG vacc inc: t.ion. '!'ytler ( 211) preps.red a 
1<1emorandum on BCG for the Tuberculosis Ascocietion, The 
Joint Tuberculosis Counthil &l~d the National _A.ssocie. tion for 
the Prevention of ~uberculosis iL 1946. This presentee an 
evaluation of deta with conclusions in fever of ECG. After 
much controversy the British Public Health Authorities have 
finally consented to be[in experiments w\th BCG. They ere not 
yet convinced tr,:::t it shoulc be introduced as e public heelth 
measure. 
The attitude to~erd ECG in the United Stetes hes 
changed remarkably in the last few years. The incident at 
Lubeck and the experiments of Petroff served to put t:.e vac-
cine in disrepute. :r?ecause of t~:e good results in Sce;;dina.via 
and the many inauiries about the health department's policy, 
a Conference on BCG Vacc in2 tion was cEd.led e t ~·'ashinston on 
(II.. fo, J-30). 
Sept. 7, 1946~ Arter careful consi6ere~lon of the vast litera~ 
ture on BCG the conference (attended by 13 eminent tubercula-
sis authorities) reached the following conclusions: 
1. BCG vaccinEtion confers increased resistance to 
tuberculosis for the perto~ covered in tte stu6ies moCe. The 
protection is not absolute. ~-o ce.ses of proved :proe:ressive 
disease have resulted from ase of ECG. It can be used without 
causing severe locEl reactions. 
2. A single laboratory should be estc.t-lished for 1' 
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reseE,rch procre:.'1s. Extensive inves tiga tior:s r::ould be ce.r.:."'ied 
on by recognized groups during t~e coming years. The intracu-
taneous method is recomrc:ended for Le stuciE s usec5, 'ri~- th re-
a 
search into other met:-,oos. 1~'ays of standa:rvizinc techn:._czues of 
prepErstlon of a potent 226 stable vaccine should be developed. 
There should be international cooperation in plans for produ-
cin~ the vaccine e~nd in comparing verious streins used in 
verious perts of t~e world. 
3. A study to determine immedi£te and lon5-range re-
sults wes recomKended to be undertaken in a com~unity of 
100,000 or more people. 
4. The vaccine should not yet be made availalle to the 
general practitioner for vaccination of the general popula-
tlon. It is perticularly useful for those 5roups exposed to 
infection, e.g. Amer~can :nd ens, inmates a~d e~plo~ees of 
mental institutions, doctors, medical students, nurses, em-
ployees of [eneral hospi te.ls and sa.netoria in l·hic:n there e..re' 
no adecuete control measures a.nd economice.lly anC. socially 
underprivileged peoples e.n:ons 1-·'bom the tuberculos!.s mortality 
is ~ery high. 
5. More study is needed concernlnc the duration 
of tuberculin sensi ti vi ty efter veccim:tion end tt.e neeo_ for 
reve.cc i ne. t'i on. 
In June, 1947 a Seminar on FCG we;s pre sen ted be for~; 
the National Tuberculosis Associstion in session at San Fran-
·--=*== 
-53-
li ,~o==~=-t--=~~~c t aco~~rF. --~T:=~=A:-rtb.t.rr'Tfyers--==rT92) <n~c'en"Eue:"tB-'c=-v'~e'·contro-v·ersj~=~~== 
" !! 
1 over BCG by stating that our knowledge of i~munity in tuber-
culosis is inaaequate, that BCG has not adequately irr~unized 
animals against tuberculosis, that if it were efficacious, 
it would not be still controversial, that it does not prevent 
virulent tubercle bacilli from enterin[ t_ e body and that it 
has not been proved to his satisfaction thet BCG is harmles~. 
It is hoped thc:t the studies nov: co't?ttemplated by the L S. 
Public Health Service will provide enough ev·::.cence so thst 
the controversy over the value of BCG will finally be settled. 
. ' 
One study with BCG has begun in !,'uskogee County, 
Georgia, with headquarters in Columbus.(66,192). ECG has 
ti 
ji been administered to tuberculin negative wlJ.: te ond 2~egro 
jl 
;I schoolchildren. ~'~onva.ccino ted controls are to be follov1ed 
:i 
i1 up vlith periodic reexaminEtions for at least 5 veers. The ii " 
vaccine is produced by the Tice La~oratories in Chicago, th• 
headquarters for the country. The veccine is being adminis-. 
tered to a number of groups in different psrts of the coun-
try for studies in groups subject to high tu~erculosis ~or-
tali ty and mortid i ty. Studies such as these have ·been bee;un ' 
at the Phipps Institute,Phila. and in Earle~. It is hoped 
that efter 2C years of study definitely reliable eata will 
h&ve teen collected. 
The policy of the American TrudeBu Society, announ-; 
ced in the Bulletin received ttis week, is similar to that 
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as a substitute for approved hygienic ~easures or public 
health programs designed to prevent or minimize tuberculous 
infection and disease. 
Pope(l59) re~orts thet the Mass. repart~ent of Pub~ 
lie Health offered BCG to nurses at Boston City vospital a~d 
Kassachusetts General Eospital in ~ovember 19~7. Some 70 tu-
berculin negative nurses were immunize~. Student nurses will 
be offered the vaccinetion also in ~Erch 194E. The vaccine-
tion is ~eing offered to students at Earv2rd and Tufts 
medical schools. 1.·accination is given on a volunteEr basis 
to students at the University of Illinois and University of 
California. Other medical schools are considering offeri~g 
it to t~eir students. There is a possibility th·t ~aston 
University School of Medicine will soon follow suit. 
It is true that the death rate from tuberculosis 
in the United Sta~es has declined from 19~.4/lGO,OOC in 1900 
to 39.4/lCO,COC i.n 1945, but it ranks first us "' ce.u:~e of 
' death :n the age group 18-40,thus s~owins their need of prot~c 
tion. 
VII. OTHER USES FOR BCG 
1. In Tuberculin Testing- romingo (73) with an e:x-
tract of PCG wtich upon adcinistration to a~imels gives a 
tuberculin re!':'ction 1;Il;ich is more intense 2nd lesting. than 
ob~ained with any other tuberculin. He observes thet his 
BCG extract slves a .. igh per ce~t of positive reactions in 
P.P.t. and c.~. More recently, Ustvedt a .. d Aanonsenl72) have 
'· --~=--1=~-=--===-""-'"-'~~====---===o-=·--=-·========··-c:7CC ... c_c- o·oco,_:·"o"-===co·~.--c.·.--=· ·--~·-''-'"'co=-.~==<F,' ===== 
=== ,, 
vi"ith two grampphone needles on a holder. They found a non-
specific,specific and delayed reaction. The specific reactio4 
~ ! 
began on the second or third day, reacheo its m.sximum on the 1 ' 
seve. th. A definitely infiltrated, brownish red papule 2-10 
mm. in diameter developed. They think it is more sensitive 
than the Mantoux test and may soon be esed to dlstincuish 
bet,-veen infected e::d noninfected persons v•ho are tuberculin-
negative. 
2. Diagnosis of Sarcoidosis - Forssman(E2) has 
EGG-vaccinated 6 patients with sercoidosis percutaneously. 
Excision of ~he papules formed in one patient gave e positiv~ 
histological picture of sarcoidosis; the test "'''.'a"s neg2 tive 
in the other five. It is suggested that the test is worthy 
of further trial. 
VIII. SUMMARY ANr CO}TCLUSIONS 
During the twenty years that BCG has been in use, 
over five million people have been vaccinated. Eo,Iever, in 
I 
spite of its long use there is still controversy in some coun-~ II 
:i 
tries regarding its 7alue. The results of experi3ents lack it 
:: 
uniformity because of variations in teehnique, differences 
in age and rate of growth of the culture, differences in 
doses and route of ad~inistration and inaccurate control 
-56-
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Exaggerated cl~ims have been mrde for BCG. It has no 
prophylactic influence on late tertiary pul~ocPry tuberculoeis, 
on bone o~d joint or genito-urinary tuberculosis. In spite of 
the exaggerrted cl~i~s a~d u~scientific analyses of d~ta there 
are many sincere, qualified workers w~o ers convinced of its 
efficacy when properly used. 
A completely detailed study of ell tte ~ork that ha~ 
been done is beyond t~e sco~e of this paper. An attempt has 
been made to summarize t~e ~ore important studies and correlate 
the de. ta \·I"_ th recent reports. From our peru sa 1 of t~.e l i tere-
ture we conclude that it seems well established t~at BCG is 
harmless to man, and that by inoculstion i~ increrses resis-
tance to tuberculosis. The ~esree ene 6urrtioc of tte i~munity 
produce(' is not yet ·orec~sely k!';O~··n, but the i~nrnunit,;r is 
known not to be permanent. The overell recults froi adxi~is-
tration to l'l'JmeJ:.s is fevoreble for ECG. 
BCG vaccinRtion has teen widely .J.. ""! • --. ....., :"I • eccep ~.,eo li.: >:,ccJ:.ol-
I 
c~untries. Controlle~studiEE of its effect·ve~ess nre l~ 
progress in Britain and the United St£iEs. 
The develoD~ent, prepar2tian, B{~lntstr~t~on and use 
of the vecc'Lne l12s been discussed along i:.'i th cr:. -:-~_c'.ls;:;s of 
the early work, present~tion of protlerns rttendins vEccinstion 
and possible other uses f~r ~CG. T~e vaccine is recom~ended for 
infants exposed to tuberculosis and ex osed groups such as 
nurses, medical students, a·d doctors. 
========--=-'-"'-''·''·'~ '=' .. -.,==--= -.. · .. · ... ·"''------~=-=-"i"·"======== 
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However, the use of ECG should not supersede regular public 
health measures. 
I•:any workers are ::..coking forvmrd vr". th hopefulness to 
the published resul~s of studies ~ow telng undertaken to 
determine tl.1e effectiveness of "!?CG. Eore kno·,·leoge is defi-
nitely needed concernins the actual degr~e of im~unity con-
i! ferred, dure tion of irnr.mni ty, effectiveness of the vc-Lccine 
,I . 




racial groups ''ri th varyine; dee-.-rees of resistc:nce, effecti_ve- i\ 
;I 
ness when given to vErious age groups, ax:d the effectiveness !i 
I. 
of t e vaccine when prepared with different culture media. 
It is hoped tl·;a t i·re shall soon have the e.::1SVi8BS to,, 
the ]rotlems regarding ?CG vaccinetion. Until then, it is 
better to restrict its use to groups definitely exposed or 
li 
to be exposed to virulent infectio.r" 1·:~.0 are tuberculin nega.- !' 
i! 
tive at time of vaccination. W 11 (2 r-,r--\ h'"'s · e~ a gren C~/ a lSSU Q tilis n 
plea to colleagues who still hesitt~te to use 'SCG:"Give BCG 
vaccination a fair trial, and you will be convinced of its 
sffectiveness 11 • Years of study ma.y prove thE: truth of this 
stc-tement. 
. . . . . .. ~- .. · 
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